Podcasts about Johns Hopkins

Most medical imaging happens after a symptom, injury, or abnormal test gives a clinician a reason to look. But what changes if imaging becomes a more routine measurement, creating a record of the body before something goes wrong?In this episode of Next Level, Mike Haney talks with Dr. Daniel Durand, chief medical officer at Prenuvo, about whole-body MRI as a test case for a broader shift from episodic medicine toward longitudinal health data. Whole-body MRI is controversial, and Durand is clearly an advocate. The conversation takes the skepticism seriously, then asks a larger question: as measurement gets cheaper, more frequent, and increasingly visible to patients themselves, how should medicine decide what is worth knowing?Free course: Improve your metabolic healthGet our free email course on how glucose, nutrition, exercise, sleep, and measurement can help you build habits that support better energy and long-term health: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://levels.link/wnl⁠What We Cover:How X-rays, CT scans, ultrasound, and MRI differ, and why radiation matters when you start thinking about repeated imagingWhat whole-body MRI sees well, and where CT, colonoscopy, or blood-based approaches may still be betterThe concerns around incidental findings, overdiagnosis, anxiety, and unnecessary follow-up, and Durand's response to themWhat the current cancer-detection evidence for whole-body MRI does, and does not, establishWhy having prior scans could help distinguish a stable abnormality from something genuinely newHow faster scans and AI interpretation could eventually connect imaging with genomic, proteomic, and other health data

The abortion debate is ultimately a worldview debate: What is a human being? Where does human value come from? Who is God? What is freedom? And is morality objectively true, or something we construct for ourselves?In this episode, Scott talks to Scott, and the second Scott is none other than esteemed pro-life apologist Scott Klusendorf, bestselling author of The Case for Life. Together, they unpack the competing worldviews behind abortion and explore why defending unborn life is an essential part of Christian discipleship and the Great Commission.We explore how naturalism, postmodernism, and the biblical worldview lead to radically different conclusions about human dignity, truth, morality, choice, and the right to life. We also discuss the state of the pro-life movement after Roe v. Wade, the debate between incrementalism and abortion abolitionism, the role of the Church, and how Christians can make a clear and persuasive case for life in our current cultural moment.Who is the Disciple Nations Alliance (DNA)? Since 1997, DNA's mission has been to equip followers of Jesus around the globe with a biblical worldview, empowering them to build flourishing families, communities, and nations.

The CEO of the AARP is on a mission to have all of us recognize that people over 50 are an economic force. Their households account for 56 cents of every dollar spent in this country. Workers over 50 make up more than 40% of the workforce. Dr. Myechia Minter-Jordan joins Cladia to talk about what America would look like if our culture, workplaces, products, infrastructure and policies actually reflected this reality.Claudia and Myechia cover: Why caregiving has to move from a private family burden to a public policy priorityWhat innovators get wrong about older adultsHow closing the 12.5-year gap between lifespan and healthspan could reshape what we build, fund and prioritizeDr. Minter-Jordan says there is an economic and business rationale for moving to a longevity economy: “Our demographics are changing, people are living longer, they're staying in the workplace longer, there are now five generations in the workplace. So all of these pieces together have created the urgency for us to think differently about aging. “Relevant LinksGet more information about joining AARPFind more details on the AARP Community Challenge Grant ProgramRead the Credit for Caring Act Dr. Minter-Jordan mentionedAbout Our GuestAs CEO of AARP, Dr. Myechia Minter-Jordan leads the world's largest nonprofit, nonpartisan membership organization, harnessing the power and passion of almost 2,300 staff members, 60,000 volunteers, and numerous strategic partners. Dr. Minter-Jordan, who was named CEO in November 2024, is an accomplished physician, passionate advocate, and innovative leader who deftly merges a passion for social impact with the business acumen to make strategic decisions, foster meaningful collaboration across engaged teams, and successfully lead organizations through periods of rapid change and growth. Throughout her career, she has fought to shine a national spotlight on the importance of social equity and the far-reaching impact of philanthropy and giving back. After a successful early career in academic medicine at Johns Hopkins, where she was an attending physician and instructor, she was inspired to serve as Chief Medical Officer and ultimately President and CEO of the Dimock Center, one of the largest community health centers in Massachusetts.Dr. Minter-Jordan's journey to transform the health care industry continued at the CareQuest Institute for Oral Health in Charlestown, Massachusetts, where she served as President and CEO from 2020 until 2024.Dr. Minter-Jordan has consistently prioritized giving back through her service on a wide range of boards and commissions, including BlueShield of California, Yawkey Foundation, Point 32 Health, and The Boston Foundation. She has received numerous awards for her contributions, including Harvard Medical School's Reede Scholar Vision Award and the Terrance Keenan Leadership Award in Health Philanthropy from Grantmakers in Health.Dr. Minter-Jordan is a graduate of Brown University and earned her MD from the Brown University School of Medicine and her MBA from the Carey School of Business at Johns Hopkins University. She holds an Honorary Doctor of Public Service degree from Northeastern University and an Honorary Doctorate of Humane Letters from Newbury College.SourceConnect With UsFor more information on The Other 80 please visit our website - www.theother80.com. To connect with our team, please email claudia@theother80.com and follow us on twitter @claudiawilliams and LinkedInSubscribe to The Other 80 on YouTube so you never miss our video extras or special video episodes!

Is your relationship running on autopilot, derailed by misunderstandings, stress, or simply the exhaustion of daily life? Too often, we fail to recognize how the health of our brains—our most vital organ—directly shapes the way we connect, love, and even argue with those closest to us. What if the difference between disconnection and deep intimacy is all in your head—literally? In this episode, listeners will discover how brain health impacts everything from emotional regulation to sexual intimacy, and why tending to your mind's well-being is foundational for thriving relationships. The conversation explores how stress, fatigue, trauma, and even everyday routines influence the way we interact with our partners, sharing practical neuroscience-backed strategies to build resilience, practice self-awareness, and foster genuine connection. Dive in to learn why caring for your brain might just be the ultimate relationship hack. Dr. Majid Fotuhi, MD, PhD, is a world-renowned neurologist and adjunct professor at Johns Hopkins. In his new book, The Invincible Brain: The Clinically Proven Plan to Age-Proof Your Brain and Stay Sharp for Life (March 3, 2026 // Harper Wave), Dr. Fotuhi reveals that in just 12 weeks, it's possible to prevent and even reverse cognitive decline - at any age - in over 80% of patients.   Episode Highlights 03:30 The brain as the source of emotions and relationship reactions. 09:33 Personal awareness and communicating emotional states in partnerships. 11:30 Taking pauses: Self-check and sharing needs during stress. 13:43 The nervous system's role in stress, intimacy, and brain health. 19:33 Trauma, memory, and the brain's ability to rewire through experience. 23:15 Challenging old narratives and the power of cognitive behavioral change. 26:07 Metacognition: Understanding and questioning our perceptions. 28:43 Belief systems, relationship interpretations, and subjective reality. 33:36 Emotional vs. logical brain circuits and habits of thought. 36:45 Healing from trauma: Neuroplasticity and creating new life patterns. 40:47 Sexual intimacy: The brain's role in arousal, connection, and desire. 43:42 Stages of sexual arousal and gender differences in orgasm. 45:36 Building a healthy brain: The five pillars and empowerment strategies.   Your Checklist of Actions to Take Pause and Check In: Before reacting in a relationship, take a moment to pause and ask yourself if your brain is in a healthy, rested state. Communicate Your State: Let your partner know when you are feeling tired, stressed, or grumpy, and request space or support as needed. Practice Metacognition: Develop insight into your own thoughts and reactions, recognizing that your perceptions are shaped by past experiences. Use Calming Techniques: Implement short breathing exercises, such as the 6-3-6 breath technique, to reset your nervous system and reduce stress in moments of conflict. Be Mindful of Sympathetic Overdrive: Identify if you are constantly in stress mode (rushing, feeling late, overbooked) and intentionally schedule downtime to invite the parasympathetic ("rest and digest") system. Engage in Brain-Healthy Habits: Prioritize exercise, optimal sleep, Mediterranean nutrition, stress reduction, and brain training for overall brain health and relationship functioning. Slow Down Intimacy: Extend foreplay and create a relaxed, affectionate environment before sexual activity to foster better physical and emotional connection. Challenge Old Narratives: Work with a therapist or on your own to identify and question limiting beliefs from your past, and consciously reinforce positive new pathways in your brain.   Mentioned The Invincible Brain (*Amazon Affiliate link) (book) The Invincible Brain Masterclass (free online course) The Invincible Brain App (Apple App Store link) (app) The Invincible Brain App (Google Play Store link) (app) Relational Health Assessment   Connect with Dr. Majid Fotuhi Website: drfotuhi.com Facebook: facebook.com/drmajidfotuhi X: x.com/drfotuhi YouTube: youtube.com/@DrFotuhi Instagram: instagram.com/dr_fotuhi LinkedIn: linkedin.com/in/majid-fotuhi-md-phd TikTok: tiktok.com/@dr.fotuhi  

What does the gut have to do with the heart in scleroderma? Quite a lot, as it turns out. In this episode, we talk with Dr. Zsuzsanna McMahan about new findings from the GENISOS cohort exploring the relationship between gastrointestinal and cardiac manifestations in systemic sclerosis, including the striking timing and strength of these associations and what they might reveal about shared disease mechanisms. Then we shift gears to the realities of academic medicine: Dr. McMahan shares lessons from moving from Johns Hopkins back to UT Houston, rebuilding clinical and research programs, forging new collaborations, and, perhaps most importantly, deciding what to say yes to and what to leave on the table The Gut–Heart Axis in Systemic Sclerosis: Evidence From a Large Prospective Early Disease Cohort 

My guest today is Will Howell, the inaugural dean of the School of Government & Policy at Johns Hopkins, which welcomes its first class in fall 2028. His argument is that the standard policy masters degree is no longer fit for purpose. I happen to agree.Two disclaimers: I took Will's class as an undergraduate at the University of Chicago, and I'm a Journalist-in-Residence at his school now.Thanks to Harry Fletcher-Wood and Shadrach Strehle for their support in producing this episode. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.statecraft.pub

Could calming overactive mast cells help with chronic fatigue, brain fog, and food reactivity? Dr. Ruscio explores remarkable improvements reported in a Johns Hopkins case series using cromolyn sodium—a mast cell stabilizer developed from the plant compound khellin. Learn how it works in the gut, dosing and safety considerations, and how it may help highly reactive patients tolerate treatment for underlying triggers.   ✅ Start healing with us! Learn more about our virtual clinic:  https://drruscio.com/virtual-clinic/  

Click here for the quiz: amenkaur.com/quizA difficult boss, a toxic relationship, or people who never saw your worth can leave you doubting yourself, even when you know you're good at what you do.So when someone finally praises you, you brush it off. Or it makes you want to cry. The problem isn't that you can't take a compliment. It's that difficult people chipped away at your sense of your own value, and your brain is still predicting from that old map.In this episode, I share five lessons to help you know your value again and take back your confidence:Why deflecting praise is a signal, not a flawHow judgment and shame keep good things out, and why the people who can't see you may not have the capacity toWhy comparing your weaknesses to other people's strengths hides your real valueHow self-compassion gets your problem-solving brain back (the one most people get backwards)Why your value grows as you express itAlong the way, we look at the brain as a prediction machine, a famous experiment with kittens, and what the research says about judgment, stress and self-doubt.Know your value. Express your value. Receive your value.Take the three-minute quiz to see what's holding you back and where to start: amenkaur.com/quizWant to work with me? Book a career diagnostic: https://amenkaur.typeform.com/diagnosticResearch mentioned: Baumeister et al. (2001), Bad is stronger than good Tangney, shame and guilt Blakemore and Cooper (1970), visual development in kittens Festinger, cognitive dissonance and social comparison Dickerson and Kemeny (2004), stress and social evaluation Gerber, Wheeler and Suls (2018), social comparison meta-analysis Vazire (2010), self-other knowledge Arch et al. (2014), self-compassion and stress Crocker and Wolfe (2001), contingencies of self-worth Vallerand, harmonious and obsessive passion Arnsten, stress and the prefrontal cortex David Linden, Johns Hopkins, and Lisa Feldman Barrett on the predictive brain

"Over 90% of the time, there is some change recommended to the care path someone is on. Oftentimes we make two to four separate recommendations." - Peter Bridges, AccessHopeCancer is one of the largest cost drivers in any self-funded plan, and most of the strategies built to manage it focus on price. Peter Bridges argues the bigger lever is making sure the patient is on the right treatment in the first place.Only about 20% of cancer patients are treated at one of the country's 57 NCI-designated comprehensive cancer centers. The other 80% get care locally, from oncologists seeing a full schedule across multiple cancer types while the science moves faster than any one doctor can track. That gap shows up in outcomes, and it shows up in claims.AccessHope closes it by bringing subspecialists from centers like Dana-Farber, Johns Hopkins, and Fred Hutch directly to the local oncologist. The diagnosis is identified in claims data, the treating physician is contacted, and the patient never has to travel, switch doctors, or ask for help.We get into why lung cancer isn't a single diagnosis, why most local oncologists welcome an expert review rather than resist it, and why working-age adults now make up more than half of new cancer cases. Peter also explains why getting someone onto the right treatment early is the better financial decision for the plan, and what an employer actually has to do to put this in place.If cancer claims are a line item you worry about every renewal, this is the episode for you. Tune in.Thank you to our 2026 sponsors!ParetoHealth: ParetoHealth empowers midsize employers with a long-term solution to reduce volatility and lower overall health benefits costs. Visit https://www.paretohealth.com/fully-insured-vs-self-funding-with-paretohealth-spencer-podcast/?utm_source=youtube&utm_medium=referral&utm_campaign=SelfFundedwSpencer to learn more.Samaritan Fund: A program that connects those who need help to the support they need. We are proud to offer the Samaritan Fund Program. Visit SamaritanFundProgram.com to learn more.Vālenz Health: We're Vālenz Health, your partner in improving health literacy, reducing plan spend, and delivering high-value healthcare. Visit ValenzHealth.com to learn more.Imagine360: Imagine360 helps self-funded employers save on healthcare with smarter health plans. Cut expenses by 20-30% with custom solutions. Contact us today at Imagine360.com.Chapters:(00:00:00) Intro: Bordering on Cruel(00:05:12) Meet Peter Bridges and AccessHope(00:11:40) The 80% Treated Outside Top Cancer Centers(00:17:25) Lung Cancer Isn't One Diagnosis(00:23:08) Finding Cancer Patients in Claims Data(00:28:44) Inside an Expert Review(00:34:30) Why 90% of Reviews Change the Care Path(00:40:02) Why Local Oncologists Say Yes(00:45:37) Cancer in Working-Age Adults(00:51:15) Why the Right Treatment Is the Cheaper Treatment(00:57:06) Putting It in Place as an Employer(01:03:22) Stories From the Field(01:08:40) Closing ThoughtsKey Links for Social:@SelfFunded on YouTube for video versions of the podcast and much more - https://www.youtube.com/@SelfFundedListen/watch on Spotify - https://open.spotify.com/show/1TjmrMrkIj0qSmlwAIevKA?si=068a389925474f02Listen on Apple Podcasts - https://podcasts.apple.com/us/podcast/self-funded-with-spencer/id1566182286Follow Spencer on LinkedIn - https://www.linkedin.com/in/spencer-smith-self-funded/Follow Spencer on Instagram - https://www.instagram.com/selffundedwithspencer/

Yashvier Kosaraju, who goes by Yash, is the Chief Information Security Officer (CISO) of a16z, 4 months into the job when this was recorded, which by his own measure feels like about a year. The job covers the firm's corporate environment, its cloud controls and its pitch decks, and the part that makes him useful to this audience is that a16z sits close enough to its portfolio companies that founders bring him their security problems directly. So host Jon McLachlan starts there. When does a startup make its first security hire, and when does that become a head of security? Yash separates the two hard. The first hire is a staff or senior staff engineer who can work independently, someone in the code and the infrastructure rather than someone building a team, and the trigger is a risk decision about what data you hold and what happens if it walks. Headcount has nothing to do with it. Where that person sits matters as much as when you hire them, because an engineer without enough context and access can't execute. The head of security comes much later, when the company is big enough to need a dedicated leader in the seat. Then the sales version of the same question, which is the one founders feel first. A big client asks for a call with your security leader, or for a named contact they can reach in an emergency. Yash's answer is that this is the wrong moment to go hire a head of security, and he lays out the 2 routes he'd take instead. Fractional CISOs come up, and he calls them a good resource for jumpstarting a program. The middle of the episode is AI, and he does neither the optimistic version nor the doom version. The security market is saturated with vendors, he says, where every feature of what ought to be one suite is its own company, and for the first time in his career he can't tell you how long consolidation will take. On offense, AI is good enough at working through known vulnerabilities, the published Common Vulnerabilities and Exposures (CVE) list, to overwhelm a defense, and the cost per exploit is falling for the attacker. His forecast is 12 to 18 months of painful catch-up, after which whole classes of vulnerability and whole categories of tooling stop being necessary. What he wants gone specifically is code security. Static application security testing (SAST) and software composition analysis (SCA) exist because humans write insecure code, and if agents are writing most of it, he'd like them writing it securely by default. His real worry sits outside the valley. The rate of AI adoption here is nothing like the rate anywhere else, and attackers ramping up on AI don't have to come to Silicon Valley to use it. The companies that haven't adopted, or that can't afford the tokens to build a defense, are the ones on the other end of that curve. He puts it plainly. The cost of not adopting AI is higher than the cost of not adopting anything that came before it. Jon takes it to agents, and this is where the episode earns its title. Prompt injection is unsolved. The defense everybody points at is the accept-this-action prompt your coding agent throws up before it does something, and his read is that it stops functioning around the third click, when people click through without reading. So a16z adopts AI fast and scopes it deliberately instead. For an AI tool, the vendor review he cares about starts with what the tool can reach, and whether that connection writes back or only reads. The pen test and the questionnaire still get run, and on an AI tool they aren't where the risk sits. The other half of that is a rule about how his team answers requests. They don't say no, because a no costs you twice. Whoever asked stops asking you, and uses the thing anyway. Also in this one. Why the security teams of the next 2 years live much closer to the code, and what changes when a finding stops being a list of packages to upgrade and becomes a pull request one agent opens and another reviews. Where testing goes once the code layer is handled, and why business logic is the part AI is worst at. The return on investment conversation nobody has solved, including his own example of the same task costing wildly different amounts depending on how fast you asked for it. Why he doesn't expect the frontier labs to be the ones who show you that price. What a16z's actual AI mandate was, which had nothing to do with spending more. One cryptography course in India that turned into a master's at Johns Hopkins and 15 years in the field. Why his proudest moments are other people's promotions, and the correction he makes when Jon calls that giving back. The job he left in under 2 months. And why he'd decline the meeting with his younger self. He's hiring, and he says so on his way out. Brought to you by YSecurity, the security team that works next to yours. Your first 8 hours with 40+ security engineers are free at ysecurity.io/startups.

"Over 90% of the time, there is some change recommended to the care path someone is on. Oftentimes we make two to four separate recommendations." - Peter Bridges, AccessHopeCancer is one of the largest cost drivers in any self-funded plan, and most of the strategies built to manage it focus on price. Peter Bridges argues the bigger lever is making sure the patient is on the right treatment in the first place.Only about 20% of cancer patients are treated at one of the country's 57 NCI-designated comprehensive cancer centers. The other 80% get care locally, from oncologists seeing a full schedule across multiple cancer types while the science moves faster than any one doctor can track. That gap shows up in outcomes, and it shows up in claims.AccessHope closes it by bringing subspecialists from centers like Dana-Farber, Johns Hopkins, and Fred Hutch directly to the local oncologist. The diagnosis is identified in claims data, the treating physician is contacted, and the patient never has to travel, switch doctors, or ask for help.We get into why lung cancer isn't a single diagnosis, why most local oncologists welcome an expert review rather than resist it, and why working-age adults now make up more than half of new cancer cases. Peter also explains why getting someone onto the right treatment early is the better financial decision for the plan, and what an employer actually has to do to put this in place.If cancer claims are a line item you worry about every renewal, this is the episode for you. Tune in.Thank you to our 2026 sponsors!ParetoHealth: ParetoHealth empowers midsize employers with a long-term solution to reduce volatility and lower overall health benefits costs. Visit https://www.paretohealth.com/fully-insured-vs-self-funding-with-paretohealth-spencer-podcast/?utm_source=youtube&utm_medium=referral&utm_campaign=SelfFundedwSpencer to learn more.Samaritan Fund: A program that connects those who need help to the support they need. We are proud to offer the Samaritan Fund Program. Visit SamaritanFundProgram.com to learn more.Vālenz Health: We're Vālenz Health, your partner in improving health literacy, reducing plan spend, and delivering high-value healthcare. Visit ValenzHealth.com to learn more.Imagine360: Imagine360 helps self-funded employers save on healthcare with smarter health plans. Cut expenses by 20-30% with custom solutions. Contact us today at Imagine360.com.Chapters:(00:00:00) Intro: Bordering on Cruel(00:05:12) Meet Peter Bridges and AccessHope(00:11:40) The 80% Treated Outside Top Cancer Centers(00:17:25) Lung Cancer Isn't One Diagnosis(00:23:08) Finding Cancer Patients in Claims Data(00:28:44) Inside an Expert Review(00:34:30) Why 90% of Reviews Change the Care Path(00:40:02) Why Local Oncologists Say Yes(00:45:37) Cancer in Working-Age Adults(00:51:15) Why the Right Treatment Is the Cheaper Treatment(00:57:06) Putting It in Place as an Employer(01:03:22) Stories From the Field(01:08:40) Closing ThoughtsKey Links for Social:@SelfFunded on YouTube for video versions of the podcast and much more - https://www.youtube.com/@SelfFundedListen/watch on Spotify - https://open.spotify.com/show/1TjmrMrkIj0qSmlwAIevKA?si=068a389925474f02Listen on Apple Podcasts - https://podcasts.apple.com/us/podcast/self-funded-with-spencer/id1566182286Follow Spencer on LinkedIn - https://www.linkedin.com/in/spencer-smith-self-funded/Follow Spencer on Instagram - https://www.instagram.com/selffundedwithspencer/

Why do some people delay or decline vaccines even when the science seems clear?Dr. Mike Myers joins The Healthy Project Podcast to discuss what happens between medical evidence and the people asked to trust it.Corey and Dr. Myers discuss the return of measles, vaccine misinformation, the role of healthcare providers in earning trust, and why distrust within Black and brown communities cannot simply be dismissed as “hesitancy.”They also explore how social media has changed who people consider credible, why the COVID-19 vaccines were developed faster than many people expected, and what Dr. Myers learned while writing The Vaccine Bible.Dr. Michael T. Myers Jr. is a Harvard and Johns Hopkins-trained physician with more than 35 years of experience in primary care, pediatrics, healthcare leadership, and public health.Learn more about Dr. Myers and The Vaccine Bible at DrMikeMyers.com. ★ Support this podcast ★

Do you like thinking outside the box? How about thinking inside the petri dish? In a new study from researchers at Johns Hopkins, a team used lab-grown brain cells to...

My guest today is Tania de Jong, co-founder of Mind Medicine Australia. Tania and her husband, Peter, helped lead the push that, in 2023, made Australia the first country in the world to allow MDMA and psilocybin to be prescribed for psychiatric conditions. I wanted to understand how the hell they helped make that happen and what the rest of the world can learn from it.This episode is brought to you by:ProLon science-backed Fasting Mimicking Diet that helps activate cellular renewal through fasting, while still eating nourishing meals: https://prolonlife.com/TimMomentous high-quality creatine for cognitive and muscular support: https://LiveMomentous.com/TimAG1 all-in-one nutritional supplement: DrinkAG1.com/TimTimestamps[00:00:00] Intro from Tim.[00:02:46] The article that changed Tania's life.[00:04:39] A first psychedelic experience—and the year it took to integrate it.[00:10:17] Rick Doblin's encouragement and the birth of Mind Medicine Australia.[00:13:15] Turning regulatory rejection into a stronger application.[00:20:48] Building a grassroots movement and training clinicians.[00:23:23] Cold emails, scientific allies, and singing your way into the room.[00:31:11] A week with Ram Dass: silence, singing, and an extraordinary LSD story.[00:37:54] Bringing David Nutt—and a family's devastating story—to the regulators.[00:42:42] Dancing in the kitchen: Australia's rescheduling breakthrough.[00:43:40] From changing the rules to treating patients.[00:48:18] Why Tim thinks MDMA is still underestimated.[00:50:23] Integration beyond the session: therapy, nutrition, and exercise.[00:52:29] Scaling access and collecting real-world evidence.[00:58:13] Getting insurers, government agencies, and philanthropists on board.[01:01:39] Syrian rue, psilocybin, and learning to let go of control.[01:10:01] Dosing, expectations, and the pressure to take more.[01:12:02] The promise of group therapy and shared integration.[01:14:22] Hiring mistakes, personal attacks, and the resilience advocacy requires.[01:23:38] Turning a window of change into lasting habits.[01:25:51] Getting through to regulators and pushing for end-of-life access.[01:28:27] The bureaucratic barriers that remain.[01:31:38] What treatment costs—and why therapist time drives the bill.[01:35:07] Could shorter-acting compounds make treatment more affordable?[01:38:46] Ketamine, kratom, and the limits of “all natural.”[01:43:14] The unexpected payoff from Tim's ketamine experiment.[01:47:46] What might come next for psychedelic access worldwide?[01:49:04] Persistence versus pushiness—and knowing when to try another door.[01:54:22] Supporting patients and training the next wave of clinicians.[01:57:51] “Be curious”: exploring your inner world and walking each other home.[02:01:35] The ripple effects of sharing your curiosity—and simply asking for help.Timeline:February 2, 2015: Michael Pollan publishes “The Trip Treatment” in The New Yorker, which is the article Tania credits with setting her journey in motion.March 21, 2015: Tim releases his James Fadiman interview, “The Psychedelic Explorer's Guide” (#66). Its show notes link to “The Trip Treatment.”January 15, 2016: In 5-Bullet Friday, Tim announces support for Johns Hopkins' psilocybin research and a personal commitment of at least $100,000 toward psychedelic research that year.2016: Tania and Peter travel to the Netherlands for their first guided psilocybin experience. (Source)2017–2019: UCSF conducts the psilocybin-assisted group-therapy study involving long-term AIDS survivors that Tim helped support. (Source)May 6, 2018: Michael Pollan joins Tim for “Exploring the New Science of Psychedelics” (#313), discussing his forthcoming book (How to Change Your Mind).May 15, 2018: Pollan's How to Change Your Mind is published.February 13, 2019: Tania and Peter publicly launch Mind Medicine Australia. (Source)2020–2022: MMA applies to reschedule MDMA and psilocybin, faces rejection, and submits new applications in March 2022. (Source)November 21, 2022: David Nutt presents to Australia's medicines regulator, the TGA, supporting the case for therapeutic access. (Source)February 3, 2023: The TGA announces restricted prescribing access to MDMA for PTSD and psilocybin for treatment-resistant depression, effective July 1, 2023. (Source)January 2024: Patients begin receiving treatment under the new prescribing program. (Source)*For show notes and past guests on The Tim Ferriss Show, please visit tim.blog/podcast.For deals from sponsors of The Tim Ferriss Show, please visit tim.blog/podcast-sponsorsSign up for Tim's email newsletter (5-Bullet Friday) at tim.blog/friday.For transcripts of episodes, go to tim.blog/transcripts.Discover Tim's books: tim.blog/books.Follow Tim:Twitter: twitter.com/tferriss Instagram: instagram.com/timferrissYouTube: youtube.com/timferrissFacebook: facebook.com/timferriss LinkedIn: linkedin.com/in/timferrissSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Scientific Sense ® by Gill Eapen: Prof. Mark Mattson is adjunct professor of neuroscience at Johns Hopkins University, School of Medicine. His research includes Cellular and Molecular Mechanisms of Brain Aging and Neurodegenerative Disorders. Please subscribe to this channel:https://www.youtube.com/c/ScientificSense?sub_confirmation=1

Show Notes:Dr. Stephen Trzeciak, physician-scientist, ICU intensivist, and Chief of Medicine at Cooper University Health Care, joins Chris and Eddie to talk about the hard science behind three things doctors don't usually get research funding to study:  compassion, service, and hope. Steve walks through the peer-reviewed evidence behind his books Compassionomics and Wonder Drug, including a Johns Hopkins study showing that as little as forty seconds of compassionate communication measurably reduces a cancer patient's anxiety, and newer research showing that caring more — not less — is the antidote to burnout, not its cause. The conversation turns personal as Steve describes his own burnout and recovery, then moves into a preview of his forthcoming book The Hope Effect, unpacking hope as a trainable, three-part skill (goal power, way power, and willpower) rather than wishful thinking. It's a rare conversation where clinical research and pastoral instinct land in exactly the same place.RESOURCES MENTIONED:• Compassionomics: The Revolutionary Scientific Evidence That Caring Makes a Difference (Trzeciak & Mazzarelli, 2019) —Steve's first book, cited throughout• Wonder Drug: 7 Scientifically Proven Ways That Serving Others Is the Best Medicine for Yourself (Trzeciak & Mazzarelli, 2022)• The Hope Effect: The Science of Healing, Achieving, and Breaking Through (Trzeciak & Mazzarelli) — forthcoming, January 2027• The Hope Effect Substack — Eddie references reading articles here ahead of the book's release• Johns Hopkins University study on a brief “enhanced compassion intervention” for breast cancer patients (referenced in conversation; not named by title on air)• Becca Levy (Yale University) research on “positive age beliefs” and longevity among seniors (referenced)• Rick Snyder's Hope Theory — the psychological framework (goal / way / willpower) The Hope Effect draws onGUEST LINKS• Compassionomics (book site): https://www.compassionomics.com/• Wonder Drug (book site): https://www.wonderdrugbook.com/• The Hope Effect (Substack): https://thehopeeffect.substack.com/• Cooper University Health Care bio: https://www.cooperhealth.org/doctors/stephen-trzeciak-md• LinkedIn: https://www.linkedin.com/in/stephentrzeciak• X / Twitter — @StephenTrzeciak: https://x.com/stephentrzeciak

Did you know that you can find out about your health through your dreams?  Do you believe the power of prayer can heal? Lisa continues the conversation today with guest Dr. Larry Dossey, a Physician of Internal Medicine whose books are used as textbooks in many universities. He'll talk about documented studies about the healing role of spirituality and prayer in healthcare. Dr. Dossey talks about non-local healing through dreams. In ancient times, the nature of the illness and the therapy or treatment were found in dreams. Healing temples existed where people would sleep to find answers through their dreams. He talks about extensive research on dreams and how they can act as premonitions, including the case of Lincoln seeing his own death in a dream. He also discusses how prayer, spirituality, and religious beliefs help people to be healthier. He is studying the effects of long-distance healing and the benefits. This shows that something about us is more than our bodies. He invites us to honor the infinite being who we are. Dr. Dossey is a well-respected leader in bringing scientific understanding to spirituality and an internationally influential advocate of the role of spirituality in healthcare and wellness. During his distinguished career as a practitioner of integrative medicine, he helped establish the Dallas Diagnostic Association and served as Chief of Staff of Medical City Dallas Hospital. The author of eleven books, including the New York Times bestseller "Healing Words," he is executive editor of "Explore: The Journal of Science and Healing." Dr. Dossey has lectured all over world and at major medical schools and hospitals in the United States — Harvard, Johns Hopkins, Cornell, and the Mayo Clinic, among others. Info: dosseydossey.com

In this episode of Coming From Left Field, philosopher and cultural critic Gabriel Rockhill joins us to discuss “Requiem for French Theory: Transatlantic Funeral Dirge in a Marxist Key,” his new book co-written with Aymeric Monville. Rockhill examines how postwar French Theory—associated with thinkers such as Michel Foucault, Jacques Derrida, Gilles Deleuze, and others—was received, promoted, and institutionalized in the United States during the Cold War. He argues that the rise of postmodern and poststructuralist approaches often displaced class analysis, historical materialism, anti-imperialism, and practical socialist politics in favor of a focus on discourse, difference, and anti-totalitarianism. The conversation also explores the Ford Foundation, the 1966 Johns Hopkins conference often cited as a launching point for French Theory in the United States, Cold War cultural politics, and the wider political economy of academic knowledge production. Rockhill argues for rebuilding a class-centered, internationalist Marxism and joins a thoughtful exchange on China, Vietnam, socialism, imperialism, inequality, and the challenges of assessing existing socialist projects without demonization or uncritical celebration.   About Gabriel Rockhill Gabriel Rockhill is a philosopher, cultural critic, and professor of philosophy and global interdisciplinary studies at Villanova University. He founded the Critical Theory Workshop, an educational nonprofit established in 2008 that offers summer programs, courses, public discussions, book launches, and other forms of accessible critical education. Rockhill's research focuses on political philosophy, ideology, culture, intellectual history, the political economy of knowledge production, Marxism, and anti-imperialism. “Requiem for French Theory” and his previous book, “Who Paid the Pipers of Western Marxism?” are part of a larger effort to investigate how intellectual institutions shape political thought—and how Marxist theory can again connect to collective struggles for social transformation.   Follow Gabriel Rockhill: Resources: Order the book: https://kingsbookstore.com/book/9781685901493 Webpage: https://gabrielrockhill.com/   Greg's Substack: https://substack.com/@greggodels929536 Pat's Substack: https://patcummings.substack.com/   #GabrielRockhill#RequiemforFrenchTheory#AymericMonville#FrenchTheory#Marxism#WesternMarxism#FordFoundation#CongressforCulturalFreedom#JohnsHopkins1966conference#FrankfurtSchool#criticaltheory#CriticalTheoryWorkshop#politicaleconomy#classstruggle#socialism#communism#anti-capitalism#U.S.empire#leftpolitics#China#Vietnam#multipolarworld#GlobalSouth#PatCummings#GregGodels#ZZBlog#ComingFromLeftField#zzblog#mltoday

On this episode of Diabetes Connections In the news… The ADA conference controversy continues with a boycott now, new patch pump approved, an update on long running research to reverse type 1, plus consensus guidelines on T1D screening, intermittent fasting for type 1, a new surprising study about COVID and T1D, statins, type 2 and dementia, and lots more..  This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.  Want to let you know about a webinar I'm doing with Abbott later this month. That's Sept 23 at 7pm ET. We'll be talking about ketones, DKA and learn more about their dual CGM/ketone monitor that was just approved. Join us for a webinar September 23 Check out all of our events like Moms' Night Out and Club 1921 here. Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Transcript: On this episode of Diabetes Connections In the news… The ADA conference controversy continues with a boycott now, an update on long running research to reverse type 1, plus consensus guidelines on T1D screening, intermittent fasting for type 1, a new surprising study about COVID and T1D, statins, type 2 and dementia, and lots more.. It's all coming up right after this. (AD BREAK) Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bring you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. We are off to Detroit this week for Moms' Night Out in Bloomfield Michigan. Super excited and as usual I'm getting last minute emails and DMs about respiration from people just finding out about the event. We will always figure it out so drop me a line. But please register now for Seattle next month! Tampa will be open soon as well! Want to let you know about a webinar I'm doing with Abbott later this month. That's Sept 23 at 7pm ET. We'll be talking about ketones, DKA and learn more about their dual CGM/ketone monitor that was just approved. Great crowd already registered for that, hope you can join us. The link is in the show notes. Okay.. our top story this week: XX Member of the American Diabetes Association… are now boycotting it. The notice of the boycott condemns leadership's actions after five researchers were removed by police from its annual meeting in June. Significantly, The editors of ADA's flagship journal, Diabetes Care, have joined on in support of the boycott. "Manuscripts submitted will not be handled until the boycott is over," said Steven Kahn, MBChB, the journal's editor in chief and one of the five researchers ejected from the meeting in New Orleans, in a LinkedIn post on Thursday. Kahn told MedPage Today that "the journal boycott is like establishing a picket line. The boycott already has hundreds of signatures of people who have pledged to suspend all ADA-related activities, including: Planning or attending any meetings led by ADA leadership or the board, including the 2027 ADA Scientific Sessions Participating in board-led activities regarding the investigation of the meeting's events, or the report generated by the "so-called 'independent' committee" Engaging in all other ADA operations, including presentations, fundraisers, grant reviews, manuscript reviews, journal management, manuscript submissions, and position statements The boycott will remain active until the ADA board of directors permits an independent formal review of the organization's structure and function to ensure it "properly represent[s] its professional membership." If demands are not met, signees plan to align with existing or newly formed medical societies. https://www.medpagetoday.com/endocrinology/diabetes/122977 https://docs.google.com/forms/d/e/1FAIpQLSd4h548X9qXgkVREQ71k2gDHiU8WFAFF78wTnmS20_ntwUM0w/viewform XX A new patch pump is coming to the US.. Beta Bionics, Inc. announces FDA clearance of Mint, the Company's patch pump featuring a transformative reusable and disposable architecture that does not require recharging, integrates with industry-leading continuous glucose monitors (CGM) and enables smartphone control for iOS and Android users. The Company expects to initiate the full commercial launch of Mint in the United States in the first quarter of 2027 Mint is expected to launch exclusively through the pharmacy channel. Also announced, that Eversense 365 is now compatible with Beta Bionics Senseonics expects development of the Eversense 365-iLet integration to be completed during the fourth quarter of 2026. Commercial launch is planned following completion of integration activities in the fourth quarter of 2026, subject to required testing, validation activities and applicable regulatory requirements. No word yet on timing for Eversense with Mint. https://www.manilatimes.net/2026/09/14/tmt-newswire/globenewswire/beta-bionics-announces-fda-clearance-of-mint-the-companys-transformative-patch-pump-and-unveils-3d-intelligence-as-its-next-generation-insulin-dosing-algorithm/2424457 XX Seven years after Johns Hopkins researchers discovered a previously unknown immune cell called the "X cell," they're now exploring whether that discovery could lead to a new treatment for type 1 diabetes. In preclinical studies, researchers developed an antibody that was able to target and eliminate specific immune cells responsible for attacking the pancreas's insulin-producing beta cells, while leaving the rest of the immune system intact. The researchers say the approach is especially promising because it could potentially reverse the autoimmune process soon after a type 1 diabetes diagnosis, rather than simply managing blood sugar. The work is still in the early stages and has not yet been tested in people; additional laboratory and preclinical studies are needed before human clinical trials can begin. sclerosis.https://hub.jhu.edu/2026/09/09/federal-funds-support-type-1-diabetes-treatment/ XX A new international consensus recommends routine screening for type 1 diabetes in the general population, offering the first framework for how healthcare providers could put widespread screening into practice. The guidance recommends screening children between ages 2 and 4, with children who test negative screened again at ages 6–8 and 10–15. Screening uses a blood test to look for islet autoantibodies, which can signal that the immune system is attacking insulin-producing cells years before symptoms appear or insulin is needed. Finding type 1 diabetes early can greatly reduce the risk of diabetic ketoacidosis, or DKA, at diagnosis and may give people access to treatments such as teplizumab that can delay progression to clinical T1D. https://www.prnewswire.com/news-releases/breakthrough-t1d-convened-paper-outlines-first-international-consensus-guidance-on-general-population-screening-for-early-stage-type-1-diabetes-302875788.html   XX Eating only between noon and 8 p.m. improved blood sugar control in a small study of adults with Type 1 diabetes and obesity, while avoiding an increase in serious complications. The promising findings offer the first evidence that time restricted eating could become another tool for managing the condition. For the study, Varady recruited adults with Type 1 diabetes who were also classified as obese After six months, the time-restricted eating group showed better blood sugar results than the calorie-reduction group. HbA1c, a blood test that reflects average blood sugar over the previous several months, fell by about 0.5% on average in the time-restricted group.   Couple of things here – very small study, only 32 people in total, who were then randomly placed in three groups with different styles of eating. Also, the lead researcher says this is the first study of it's kind for type 1 – which is obviously not true – you can do a quick google search or listen to past episodes of this show.. https://www.sciencedaily.com/releases/2026/09/260909231740.htm XX A large Danish study found that COVID-19 infection was associated with a slightly lower, rather than higher, risk of subsequently developing type 1 diabetes in people under age 30. Researchers studied more than 2,100 people diagnosed with T1D and found an overall 16% lower risk following a documented COVID infection, with the strongest association—a 42% reduction—seen 31 to 180 days after infection. The reduced risk appeared primarily among people who had not been vaccinated against COVID-19, although researchers cautioned that the vaccination findings were less certain. Importantly, this was an observational study, so it cannot show that COVID infection actually protects against type 1 diabetes or explain what caused the association. Researchers say the findings conflict with some earlier studies and should be investigated in other countries and populations. https://www.news-medical.net/news/20260908/COVID-19-linked-to-lower-subsequent-risk-of-type-1-diabetes.aspx   XX   Semaglutide, a medication widely used for type 2 diabetes and weight loss, may also provide an unexpected benefit for people with asthma. New research presented at the European Respiratory Society (ERS) Congress in Barcelona, Spain, found that semaglutide use was associated with a reduction in asthma attacks of nearly 40%.   The study was led by Professor Chloe Bloom, Clinical Associate Professor in Respiratory Epidemiology at the National Heart & Lung Institute, Imperial College London, UK, and presented by Dr. Bohee Lee.       Exploring GLP 1 Drugs and Lung Health   Dr. Bloom said: "GLP-1 receptor agonists are widely used to treat type 2 diabetes and obesity. Previous research suggests that they may have anti-inflammatory effects and may improve lung-related outcomes. However, asthma and COPD outcomes have not been included as outcomes in GLP-1 drug trials.   "We wanted to use real-world health records to investigate whether people with asthma or COPD who started GLP-1 receptor agonists had fewer acute respiratory attacks."   To investigate that question, the researchers analyzed electronic medical records from the UK. They carried out four parallel studies, each involving between 20,000 and 22,000 people who had started treatment with either a GLP-1 medication or a different type of diabetes drug known as a sulfonylurea.   The results suggested that people with airway diseases such as asthma and COPD who received GLP-1 therapies experienced fewer asthma attacks and COPD flare-ups than comparable patients who were prescribed other diabetes medications.   Semaglutide Showed the Strongest Effect   Among the GLP-1 drugs examined, semaglutide appeared to stand out, particularly for people with asthma.   Bloom explains: "The effect was strongest with semaglutide, especially in people with asthma, where use of semaglutide appears to be associated with nearly a 40% reduction in asthma attacks. Semaglutide also led to a 20% reduction in COPD flare-ups."   The findings suggest that people who already qualify for GLP-1 receptor agonists because they have obesity or type 2 diabetes could potentially receive an additional benefit for their respiratory health.   However, Bloom emphasized that the results are not enough to recommend these medications specifically as treatments for asthma or COPD.   She explains: "The findings from this study are encouraging, but they should not change treatment decisions on their own. People with asthma or COPD should not start GLP-1 receptor agonists specifically for their lung condition outside current prescribing guidance. While the findings suggest that some people taking GLP-1 receptor agonists may experience fewer respiratory attacks, this needs confirmation in clinical trials." https://www.sciencedaily.com/releases/2026/09/260909005155.htm XX XX A large study suggests women with endometriosis may have a higher risk of developing type 2 diabetes. Researchers analyzed health records from nearly 3 million women in Utah and found those diagnosed with endometriosis were 46% more likely to develop type 2 diabetes than those without the condition. The association was strongest among women who had not yet reached menopause and those without obesity, a group typically considered at lower risk for type 2 diabetes. Certain forms of endometriosis, including those found outside the pelvic area, were associated with more than twice the risk. Researchers say more study is needed, but the findings suggest endometriosis may have health effects beyond the reproductive system and could eventually help identify women who may benefit from earlier diabetes screening. https://www.nih.gov/news-events/nih-research-matters/endometriosis-may-increase-type-2-diabetes-risk   XX MiniMed files FDA submission for it's first patch pump, with a planned launch next summer. To be called MiniMed fit, it would have a 300-unit insulin reservoir and would accommodate up to seven days of wear time. MiniMed also completed enrollment of a pivotal trial for a fully closed loop algorithm, which would calculate the amount of insulin a person needs throughout the day, even if they don't announce meals or count carbohydrates. Interestingly, on an investor call, the CEO acknowledged that CGMs have been their – quote – Achilles' heel for a very long time" and that their newest sensor has helped drive insulin pump growth. https://www.medtechdive.com/news/minimed-submits-new-patch-pump-for-fda-clearance/829313/ XX A new study based on national health registers in Denmark suggests starting statin treatment after a type 2 diabetes diagnosis could lower the risk of dementia, and it seems that the sooner patients did, the better. The research, published in The Lancet Regional Health, is an observational study, meaning it can find statistically relevant patterns at the population level, but doesn't necessarily explain what caused those patterns. The results, however, were interesting enough that the researchers, led by medical doctor Tummas Ternhamar of the Copenhagen University Hospital, are urging doctors to consider statin therapy when diagnosing type 2 diabetes patients. "Statins seem to be underused in patients with type 2 diabetes, despite their protective effects against cardiovascular disease." https://www.sciencealert.com/statins-linked-to-lower-dementia-risk-in-massive-type-2-diabetes-study XX Big sports news with type 1. Alezander Zverev wins Family was at the heart of Alexander Zverev's U.S. Open triumph on Sunday as the German saluted the members of his inner circle and paid a heartfelt tribute to his mother for refusing to let diabetes define his future. The ​top seed beat American Ben Shelton 6-3 7-6(2) 5-7 6-2 at Flushing Meadows to finish a spectacular year at ‌the Grand Slams in which he proved his doubters wrong by going from perennial nearly man to two-time major champion. Shortly after his victory, Zverev reserved special praise for his mother Irina, a former professional tennis player, and credited her with ensuring type 1 diabetes never limited his ambitions in life. "When your 4-year-old son is diagnosed with diabetes and doctors in the office ​tell you that life and sports will be very limited for that child, it takes a very strong mother to ​say 'my son will be whatever he wants to be'," Zverev said. "'If he wants to be a tennis player, ⁠he'll be a tennis player. If he wants to do something else, he'll do something else, but this illness will not define us'. https://www.reuters.com/sports/tennis/zverev-hails-mothers-belief-after-us-open-triumph-2026-09-13/ XX Also, shout out to Garrett Mitchell (Center field  Milwaukee Brewers) lives with Type 1 Diabetes and hit a grand slam immediately after having a failed insulin pump site. He was diagnosed with T1D at the age of 9. And I have a T1d mom friend who's known him since he was a kid. Just great to see athletes talking about failed insulin sets like they're just part of everyday life.. because they are. Btw it was the first grand slam for the brewers all year. XX The new Netflix movie The Runner is getting a bit of a side eye from some in the diabetes community… the Gal Gadot thriller features a child with type 1 but as usual, there are some weird inaccuracies. Ginger Vieria from Diabetes nerd has a great vide on this – I'll link it up: but they're saying things like Insulin Dispenser instead of pump.. and some other weird stuff.. but I've heard such bad things about this movie I'm not sure it's worth watching just for this. Ginger's video is though! https://www.youtube.com/shorts/o8cw_gEZj5s  

In the fourth episode of Season 5 on the Neuroethics of Psychedelics, we speak with Dr. Edward Jacobs about post-trial access to psychedelics among certain patients.Dr. Jacobs is currently a postdoctoral research fellow at Johns Hopkins' Center for Psychedelic and Consciousness Research and the Associate Director of HOPE – The Hub at Oxford for Psychedelic Ethics. He is also a contributing writer to ‘The Ethics Corner' at The Psychedelic Practitioner.In this episode, Dr. Jacobs discusses the challenges that can arise when participants who benefit from psychedelic treatments during clinical trials lose access to them once a study ends. Drawing on his work on post-trial access to psychedelics, he explores the ethical case for continued access, as well as the clinical, regulatory, and institutional infrastructure that would be needed to provide it safely and responsibly.Episode contributors:Host: Dr. Lavinia UscatescuAudio editor: Sarah Schultz

It seems like Division III football made another big splash this past weekend, and we’re not just talking about that flood that overtook Washington & Jefferson’s field at halftime vs. Keystone. No, we’re talking about another great week of games. How about unranked Randolph-Macon taking down then-No. 3 Johns Hopkins? No. 1 North Central and No. 9 Wartburg tight going deep into the fourth quarter? No. 6 UW-River Falls taking it to No. 21 Coe? No. 14 Hardin-Simmons winning at No. 12 UW-La Crosse? And none of that even includes the fact that Mount Union was 16 seconds away from losing its third consecutive game. Game balls get handed out to some of the top performances and most memorable performances in Division III from Week 2. Plus, which team held the ball for more than 25 minutes in the second half? Yes, you read that right. Who’s hitting a ton in Region 1? What’s the hullabaloo in the 2? What do you see in the 3? Who’s got questions galore in the 4? Who’s taking a long drive in the 5? Who’s getting their kicks in the 6? Randolph-Macon coach Pedro Arruza joins us for Fast Five. Plus, when Patrick pulls over the podcast car to the side of the road, what is the big question? And didn’t Pumpkin Spice season come even earlier this year? We’ll have a Pumpkin Spice Showdown in the Final Countdown. Plus we take four mailbag questions, and much more. Patrick Coleman and Greg Thomas deliver all of the goodness to your fall in this week’s edition of the D3football.com Around the Nation podcast. Hit play, or subscribe to get this podcast on your mobile device. You can subscribe to the Around the Nation Podcast in Apple Podcasts, and many other places. You can also get this and any of our future Around the Nation podcasts automatically by subscribing to this RSS feed: http://www.d3blogs.com/d3football/?feed=podcast Here’s how to find us on some of the major podcasting apps: Apple Podcasts: D3football.com Around the Nation Podcast Podcast Addict: D3football.com Around the Nation Podcast iHeart Radio: D3football.com Around the Nation Podcast Spotify: D3football.com Around the Nation Podcast Photos: Randolph-Macon athletics; Wade Gardner, d3photography.com; Hardin-Simmons athletics

A powerful conversation with neuroscientist and surgeon, Dr. Charles Limb, about music, creativity, authenticity, and what helps people thrive together  In this fascinating conversation, Izolda Trakhtenberg sits down with neuroscientist, surgeon, and musician Dr. Charles Limb to explore the powerful connection between music, creativity, and the human brain. You'll learn how creative expression fosters empathy, why improvisation can expand creative thinking, what neuroscience reveals about inspiration, and how practice, play, and even mistakes help artists grow. Whether you're a writer, musician, actor, or creative entrepreneur, this episode offers fresh insights into creative confidence, artistic authenticity, and the science behind meaningful creative work. Tune in and come away with new ways to nurture your creativity, curiosity, and connection through the arts. A Harvard graduate who earned his medical degree from Yale, Dr. Limb spent years at Johns Hopkins before bringing his groundbreaking work to the University of California, San Francisco. His research has helped us better understand how musical play, improvisation, and listening can spark creativity, strengthen connection, and even change the way we think. In this conversation, you'll gain fresh insights into why creative expression matters, what science reveals about those moments of inspiration, and how music can help you access more possibility in your everyday life. If you've ever wondered where creativity comes from, and how to nurture more of it, this episode is for you.   Connect with Izolda Website: https://IzoldaT.com Book Your Discovery Call: https://calendly.com/izoldat/discovery-call New Play Exchange: https://newplayexchange.org/users/90481/izolda-trakhtenberg What you need to know today. Choose your Functional Tarot card here. This episode is brought to you by Brain.fm.* I love and use brain.fm! It combines music and neuroscience to help me focus, meditate, and even sleep! Because you listen to this show, you can get a free trial and 20% off with this exclusive coupon code: innovativemindset. (affiliate link) URL: https://brain.fm/innovativemindset Listen on These Channels Apple Podcasts | Spotify | Stitcher | Podbean | MyTuner | iHeart Radio | TuneIn | Deezer | Overcast | PodChaser | Listen Notes | Player FM | Podcast Addict | Podcast Republic | *Affiliate Link  

As the FDA takes its first steps toward receiving clinical data in real time, what happens to regulatory operations professionals? Carla Griffin, CEO of The Sugar Water Operations Team, argues that reg ops has been kept in too small a box for years and that this shift is the opening to change that.Carla and Nick Capman get into why the hardest adjustment is professional rather than technical, how to vet technology vendors who don't understand your regulations, and the three things reg ops professionals should do in the next twelve months.A few of Carla's key takeaways:Reg ops specialists are problem solvers who've been siloed into links, bookmarks, and document constructionThe instinct that makes reg ops strong, wanting everything systematic, is what will make this shift hardestGetting reg ops and IT into decisions earlier isn't optional if the goal is getting data to FDA fasterWhen evaluating technology, look for options rather than solutions, then eliminate risk to make an option viableAsk vendors whether they understand the regulations you're held to. If they can't answer, move onPut on your FDA hat: where do the data integrity questions come from, and can you show a human was in the loop?Old technology isn't the enemy. It's just at a disadvantage nowNote that this was recorded in September 2026. The FDA's real-time clinical trials work has been developing quickly, and Carla's forward-looking comments are her own assessment rather than announced agency policy. New developments may supersede the information provided here.About Carla GriffinCarla Griffin, M.A., M.S., is CEO and Principal Operations Consultant at The Sugar Water Operations Team (SWOT), supporting emerging biotech and pharmaceutical companies across regulatory operations, submissions management, and quality systems. She has close to two decades of experience, including eight years at Esperion leading development and regulatory operations, with earlier roles at Sarah Cannon Research Institute, LIQUENT (a PAREXEL company), and Human Genome Sciences. She holds a master's in regulatory science from Johns Hopkins.About The FDA GroupThe FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle, from clinical development to commercialization, with a focus on staff augmentation, auditing, remediation, QMS, and other specialized project work in Quality Assurance, Regulatory Affairs, and Clinical Operations. Learn more: https://www.thefdagroup.com/

Arts of the Border: Fugitive Bodies at Europe's Edges (Fordham, 2025) investigates the consequences of unfolding catastrophes across the world and the displacement they continue to produce. Through recent narratives and media representations of the refugee “crisis” at Europe's edges, it tells a new story about those on the move, the technologies unleashed on them at borders, the racialized and colonial histories that inform these technologies, and the artistry with which migrants and allies bear witness to displacement. The book reorients us toward the creativity and movement of migrants themselves– their “arts of the border”—as well as toward the political force of the arts that represent them, whether in literature, documentary film, or art installations. Sanyal proposes kino-aesthetics as a framework for capture and fugitivity at borders. From kino—to set in motion—and aesthetics— relating to sensory perception—kino-aesthetics conveys the force of bodies in motion and the image in its circulation. The book examines the simultaneity of capture and escape at thresholds of illegalization, from airport detention zones to Calais's “jungle” and the Euro-African border at Ceuta and Melilla. What emerges throughout these case studies is a portrayal of border violence in its racial and colonial forms as well as an archive of refusal, fugitivity, and un-bordered imagining. Guest Debarati Sanyal is Professor of French, Director of the Center for Interdisciplinary Critical Inquiry, and currently holds the Zaffaroni Family Chair of Undergraduate Education. Affiliated with the Designated Emphasis in Critical Theory, the Berkeley Interdisciplinary Migration Initiative, the Center for Race and Gender, and the Institute of European Studies, her teaching and research interests span 19th -21st-century French and Francophone literature, memory studies, aesthetics and bio/necropolitics, critical human rights and refugee studies. She is a recipient of the UC Berkeley Distinguished Teaching Award (2012) and a Guggenheim Fellowship (2021-2022). She is currently co-PI on the Mellon-funded A Counter-Imaginary in Authoritarian Times (2024-2027). Besides Arts of the Border, Dr. Sanyal has authored Memory and Complicity: Migrations of Holocaust Remembrance (Fordham, 2015), translated into French as Mémoire et Complicité: Au Prisme de la Shoah (PUV, 2019); and The Violence of Modernity: Baudelaire, Irony and the Politics of Form (Johns Hopkins, 2006).  She has guest-edited “Time and Politics in Contemporary Critique: Entanglements and Aftermaths” (Critical Times, 2018), ha also co-edited, with Éric Fassin, Demos Anxiety: Genealogies, Rhetorics, and Politics of Great Replacement (forthcoming in Patterns of Prejudice); with Damon Young and Mario Telò, Proximities: Reading with Judith Butler (Representations 2022), and, with Michael Rothberg and Max Silverman, Noeuds de mémoire: Multidirectional Memory in Postwar French and Francophone Culture (Yale French Studies 118-119). Host Gina Stamm is Associate Professor of French at The University of Alabama, with research concentrated on the environmental humanities and speculative literatures of the 20th and 21st centuries, from Surrealism to contemporary science fiction and feminist utopias, in Metropolitan France and the francophone Caribbean. Their monograph Posthumanist Ecology in Global French Surrealism is forthcoming in 2027 from Northwestern University Press. Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Arts of the Border: Fugitive Bodies at Europe's Edges (Fordham, 2025) investigates the consequences of unfolding catastrophes across the world and the displacement they continue to produce. Through recent narratives and media representations of the refugee “crisis” at Europe's edges, it tells a new story about those on the move, the technologies unleashed on them at borders, the racialized and colonial histories that inform these technologies, and the artistry with which migrants and allies bear witness to displacement. The book reorients us toward the creativity and movement of migrants themselves– their “arts of the border”—as well as toward the political force of the arts that represent them, whether in literature, documentary film, or art installations. Sanyal proposes kino-aesthetics as a framework for capture and fugitivity at borders. From kino—to set in motion—and aesthetics— relating to sensory perception—kino-aesthetics conveys the force of bodies in motion and the image in its circulation. The book examines the simultaneity of capture and escape at thresholds of illegalization, from airport detention zones to Calais's “jungle” and the Euro-African border at Ceuta and Melilla. What emerges throughout these case studies is a portrayal of border violence in its racial and colonial forms as well as an archive of refusal, fugitivity, and un-bordered imagining. Guest Debarati Sanyal is Professor of French, Director of the Center for Interdisciplinary Critical Inquiry, and currently holds the Zaffaroni Family Chair of Undergraduate Education. Affiliated with the Designated Emphasis in Critical Theory, the Berkeley Interdisciplinary Migration Initiative, the Center for Race and Gender, and the Institute of European Studies, her teaching and research interests span 19th -21st-century French and Francophone literature, memory studies, aesthetics and bio/necropolitics, critical human rights and refugee studies. She is a recipient of the UC Berkeley Distinguished Teaching Award (2012) and a Guggenheim Fellowship (2021-2022). She is currently co-PI on the Mellon-funded A Counter-Imaginary in Authoritarian Times (2024-2027). Besides Arts of the Border, Dr. Sanyal has authored Memory and Complicity: Migrations of Holocaust Remembrance (Fordham, 2015), translated into French as Mémoire et Complicité: Au Prisme de la Shoah (PUV, 2019); and The Violence of Modernity: Baudelaire, Irony and the Politics of Form (Johns Hopkins, 2006).  She has guest-edited “Time and Politics in Contemporary Critique: Entanglements and Aftermaths” (Critical Times, 2018), ha also co-edited, with Éric Fassin, Demos Anxiety: Genealogies, Rhetorics, and Politics of Great Replacement (forthcoming in Patterns of Prejudice); with Damon Young and Mario Telò, Proximities: Reading with Judith Butler (Representations 2022), and, with Michael Rothberg and Max Silverman, Noeuds de mémoire: Multidirectional Memory in Postwar French and Francophone Culture (Yale French Studies 118-119). Host Gina Stamm is Associate Professor of French at The University of Alabama, with research concentrated on the environmental humanities and speculative literatures of the 20th and 21st centuries, from Surrealism to contemporary science fiction and feminist utopias, in Metropolitan France and the francophone Caribbean. Their monograph Posthumanist Ecology in Global French Surrealism is forthcoming in 2027 from Northwestern University Press. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/african-studies

It's time to talk Ithaca football! Hosted by Ceci Camm, with analysts Joey Scherkenbach and Nate Krajnak, the Bombers Football Podcast breaks down IC's Week 1 loss to Johns Hopkins and previews the Week 2 contest vs Alfred.

Michael A. Crane, the medical director of the World Trade Center Health Program Clinical Center of Excellence at Mount Sinai, thought he would be seeing a lot of cases of lung cancer coming into his clinic. “My greatest concern was that they were gonna get lung cancer,” Crane said. He remembers treating 9/11 first responders during the immediate recovery. Workers would put on a mask and the filter would clog up within 30 minutes. The air was thick and impossible to breathe. But 25 years later, an uptick in lung cancer hasn't really panned out in the data—so far. “Fingers crossed, fingers crossed, it might be off the table,” he said. “But of course, there's no guarantees in life, as in anything else.”In this episode of the Cancer History Project podcast, reporter Sara Willa Ernst sits down with Michael Crane to talk about the surprising twists and turns of treating 9/11 first responders over the past 25 years. He also offers his theory behind why the incidence of lung cancer didn't spike as expected—an achievement, perhaps one of Crane's proudest, that the program was able to accomplish. The WTC Health Program was able to reduce smoking among first responders from 20% to just 3%, according to Mount Sinai data.“When I die, and God asks me: ‘What did you do with your life?' I'm gonna give them that statistic and demand to get into the doors. ‘Open the doors, buddy! Look what I did here,'” Crane said. The Cancer History Project Podcast is sponsored by City of Hope, the American Society of Clinical Oncology, the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, and the University of Texas MD Anderson Cancer Center. A transcript of this podcast is available, along with an archive of related articles, on the Cancer History Project website:  https://cancerhistoryproject.com/article/michael-crane-911/ 

Do you believe the power of prayer can heal?  Are you interested in complementary and integrative ways of healing? Today's guest is Dr. Larry Dossey, a Physician of Internal Medicine whose books are used as textbooks in many universities.  He'll talk about documented studies about the healing role of spirituality and prayer in healthcare.  He also shares proof with us by discussing examples of patients who experienced healing through prayer. He talks about the power of the mind and consciousness. Dr. Dossey is a well-respected leader in bringing scientific understanding to spirituality and an internationally influential advocate of the role of spirituality in healthcare and wellness. During his distinguished career as a practitioner of integrative medicine, he helped establish the Dallas Diagnostic Association and served as Chief of Staff of Medical City Dallas Hospital. The author of eleven books, including the New York Times bestseller "Healing Words," he is executive editor of "Explore: The Journal of Science and Healing." Dr. Dossey has lectured all over world and at major medical schools and hospitals in the United States — Harvard, Johns Hopkins, Cornell, and the Mayo Clinic, among others. Info: dosseydossey.com Dr. Larry Dossey passed away recently, and we air this early Aware Show interview in his honor. This is Part 1 of the interview.

What if the same performance science used to support elite athletes, military teams, and other high-stakes professionals could help healthcare clinicians thrive?Dr. Andrea Austin welcomes Joshua Blair, Head of Insights at Arena Labs, for a conversation about the intersection of performance science, neuroscience, wearable technology, and healthcare. Joshua explains how Arena Labs adapts tools from other high-stakes industries to help physicians, nurses, APPs, and other clinicians build greater physical, mental, and emotional capacity. They explore how wearables can provide useful insight into sleep, stress, recovery, and heart rate variability while emphasizing that data is most valuable when paired with context and coaching.The conversation also moves beyond individual wellbeing to examine how aggregated insights can help healthcare organizations understand team stressors, leadership challenges, scheduling issues, and other systemic factors. Andrea and Joshua discuss why supporting individuals and changing broken systems are not competing ideas, but interconnected parts of creating healthier healthcare environments. You'll hear how they:Understand what wearables can reveal about stress, recovery, sleep, and physiologyUse heart rate variability as a personalized window into nervous-system patternsTurn wearable data into meaningful behavioral insights rather than simply reacting to scoresUse coaching to connect performance science and data to the realities of clinical lifeThink about individual wellbeing and organizational change as interconnectedUse aggregated data to help leaders identify team-level stressors and opportunitiesEmbrace individualized approaches to scheduling, workload, recovery, and performanceBuild recovery practices into life outside of workPrioritize breathing, active recovery, and sleep as foundations of wellbeingCreate healthcare environments that help clinicians flourish rather than treating them like interchangeable widgetsAbout the Guest:Joshua Blair is the Head of Insights at Arena Labs and a Johns Hopkins alum with a master's degree in science and bioengineering. He has pioneered predictive performance insights for hospital leaders and brings expertise to the intersection of performance and neuroscience. His background also includes inventing a non-invasive brain-computer device designed to monitor and augment deep sleep.At Arena Labs, Joshua focuses on translating performance science, data, coaching, and insights from other high-stakes industries into practical approaches for healthcare professionals and organizations.

Today's episode is all about routines! First, Sarah addresses a listener question around weekend planning - how to avoid feeling like the time was wasted without locking yourself in to too many scheduled activities?Then, Sarah talks all about ROUTINES -- why they deserve attention, and a wide variety of routines you might not have thought about (from your "getting ready" routine to your shutdown ritual!).Note of a FREE 2-session seminar on time management for healthcare providers (Sarah is cohosting along with two Johns Hopkins physicians) - get the signup link on today's show notes post at theshubox.com.OUR SPONSORS:IXL: Make an impact on your child's learning, get IXL now. Best Laid Plans with listeners can get an exclusive 20% off IXL membership when they sign up today at https://www.ixl.com/plans.Factor: Head to factormeals.com/plans50off and use code plans50off to get 50 percent off and 1 free breakfast item per box for 1 year, while supplies last until 10/31/2026.Boll & Branch: Upgrade your sleep with Boll & Branch. Get 15% off your first order plus free shipping at BollAndBranch.com/plans with code plans. TQuince: Find the fall pieces you'll reach for most at Quince. Download the Quince app for app-exclusive offers or go to quince.com/plans PrepDish: Make your menu planning so much easier! Try it free for 2 weeks by visiting ⁠⁠⁠⁠⁠⁠⁠⁠⁠prepdish.com/plans Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Donna Berizzi, DNP, RN, OCN, NEA-BC, Executive Director of Oncology, Johns Hopkins Hospital, & Associate Chief Nursing Officer, Cancer Service Line, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine, discusses rising oncology volumes, workforce pressures and the need to redesign care workflows. She shares how Johns Hopkins is combining predictive analytics, advanced clinical evaluation, drug preparation, and specialized care pathways to reduce delays, improve capacity, and create a more sustainable experience for patients and care teams.This episode is sponsored by LeanTaaS.

This Episode is Sponsored by SnugghugDid you know 80% of your immune system lives in your gut - and your baby gets theirs from you? Whether you had a vaginal birth or a C-section, breastfed or formula fed, this episode is going to change the way you think about your baby's health from day one.Trish sits down with Cheryl Hoy, CEO and founder of Tiny Health, the first at-home microbiome testing company for moms and babies. Cheryl's journey started with her own breech C-section birth and a mission to understand what that meant for her daughter's long-term health. What she found led her to build a company backed by scientists from Mayo Clinic, Johns Hopkins, and UCSF - and to become one of the loudest voices reminding moms that their birth mode isn't the end of the story. Trish and Cheryl dig into the science of the vaginal, gut, and skin microbiomes, why laboring (even before a C-section) still matters, and how the first 1,000 days of life set the stage for your child's immune system for years to come. This one is equal parts science lesson and permission slip - you are not powerless, no matter how your baby arrived earthside.What You'll Learn Inside This Episode:Why babies born vaginally have a different gut microbiome than babies born via C-section - and how that connects to the "atopic march" (eczema → food allergies → asthma → hay fever)Why laboring - even if it ends in a C-section - still seeds your baby's microbiome with beneficial bacteriaHow vaginal exams during labor can introduce antibiotic-resistant hospital bacteria to your babyWhy dads contribute up to 20% of a baby's microbiome in the first year (and even more with a C-section birth )What actually happens when you order a Tiny Health test, and how simple the process really isWhy "failure to progress" might have less to do with your body and more to do with how supported you felt in the roomHow feeding mode (breast vs. formula) is the #1 most impactful lever for course-correcting gut health after a C-sectionWhy the first 1,000 days - conception through age 2-3 - is the critical window for immune training, and what you can actually do about itMore from Tiny Health:Go to TinyHealth.com and use code LNM!Follow on Instagram: @tiny.healthhello@tinyhealth.comThanks to our Sponsor Snugghug: Grab the Snugghug Nursing Cover and Nursing Shirt and use code 'LNMAMA10' for 10% off! Mentioned in this episode:The VBAC Lab - Trish's course for vaginal birth after C-sectionHelpful Timestamps:00:00 Meet Cheryl from Tiny Health07:04 What Is The Microbiome12:46 Course Correcting In Early Life19:07 Results, Support, And Dad's Role20:26 Microbiome Roles at Birth23:07 Fighting for Breech Birth33:30 Tiny Health Mission and Testing36:09 Research Results and Future Care37:26 Where to Find Tiny HealthJoin The Calm Labor Birth Bundle - everything you need from bump to baby! Use code POD50 for $50 off!Over 15k mamas have used our classes to prepare for a birth that they love

Most women who deal with unexplained allergies, stubborn inflammation, heavy periods or a PMOS (formerly PCOS) diagnosis are never told to look at the same underlying cause: an immune cell most doctors were never taught to test for.Dr. Tania Dempsey, MD, trained in internal medicine at Johns Hopkins before leaving conventional practice to focus on mast cell activation syndrome, a condition she believes explains far more chronic illness in women than most doctors realize. She's the founder of The AIM Center for Personalized Medicine and helped found the International Society for Mast Cell Activation Syndromes, where she now serves as treasurer.This isn't some rare, fringe diagnosis. Dr. Dempsey estimates it may affect as many as one in five people, and in women it hides behind a long list of other labels, PMOS, endometriosis, hypermobility, unexplained heavy periods, that rarely get connected back to the same root.Optimize your sleep with the Eight Sleep Pod.Get up to $350 off at https://www.eightsleep.com/Kayla with code “KAYLA”.Join the most comprehensive *female-specific community for health and longevity optimization.* After over a decade dedicated to human performance and women's health, I created this space to share everything you need to know to optimize health and lifespan. Inside, you'll get access to exclusive protocols, live Q&As, the latest female longevity science, and a private, supportive community of like-minded women.https://kayla-barnes-lentz.circle.so/female-longevity-communityThis conversation exploresThe overreaction inside your immune system that never fully resetsWhy PMOS and mast cell activation almost always show up togetherThe natural blood thinner behind unusually heavy periodsWhere treatment actually starts, from vitamin D to advanced IV therapyConnect with Kayla:Instagram: https://www.instagram.com/kaylabarnes/TikTok: https://www.tiktok.com/@femalelongevityTwitter:https://x.com/femalelongevityWebsite:https://www.kaylabarnes.com/Spotify:https://open.spotify.com/show/4OLWWn22RGB0argbRPvAaQ?si=8e91b3c9e0ce4054Apple:https://podcasts.apple.com/us/podcast/longevity-optimization-with-kayla-barnes-lentz/id1591130227Follow Her Female Protocol: https://www.protocol.kaylabarnes.comConnect with Dr. Tania Dempsey:Instagram: https://www.instagram.com/drtaniadempseymd/LinkedIn: https://www.linkedin.com/in/taniadempsey/Website: https://drtaniadempsey.com/YouTube: https://www.youtube.com/@DrTaniaDempsey#longevity #womenslongevity #mastcellactivationsyndrome #mcas #pmos #histamineintolerance #endometriosis #womenshealth #chronicillness #rootcausemedicine #hormonehealth #inflammation

In this SRNA “Ask the Expert” episode, Krissy Dilger of SRNA introduced the Rare Neuroimmune Disorder Symposium (RNDS), a three-day hybrid event in Dallas, Texas (October 15–17, 2026) that connects individuals and families with leading experts for education on diagnosis, symptom management, rehabilitation, mental health, and research. You can view details about RNDS, including the agenda and registration, on the event page:https://www.srna.ngo/2026-rndsSRNA founder and president Sandy Siegel recounted how early community isolation and a 1999 gathering helped spark ongoing symposia [00:08:37]. He described the development of a medical advisory board and collaboration with Johns Hopkins that supported research growth, evolving diagnostic definitions, and advances such as plasma exchange and newer therapies for conditions including TM, NMOSD, ON, ADEM, AFM, and MOGAD [00:12:11]. Community support coordinator Leah Campbell shared about her neuromyelitis optica (NMO) diagnosis and described RNDS as invaluable for expert access, treatment decision support, and meaningful connection with others who share similar experiences [00:34:45].Sandy Siegel is the President of SRNA. Sandy got involved with SRNA shortly after his wife, Pauline, contracted TM in 1994 at the age of 35. At the time of her onset, Pauline was a kindergarten teacher. Sandy has been an officer and a board member of SRNA since its inception. Sandy has also served as SRNA's newsletter and journal editor during his more than two decades of service to the organization. Sandy is a cultural anthropologist with specializations in Native Americans, psychological anthropology, and culture change. Sandy has worked as an adjunct professor at Capital University, Franklin University, the Urban/Rural Program of the College of Great Falls, and the Intertribal Education Center of the Fort Belknap Reservation. Sandy retired from the State of Ohio in 2011 after more than 35 years of service. Sandy returned to college in the fall of 2011 as a photography student at Columbus State Community College. Sandy and Pauline have two sons, four grandsons, and one granddaughter.Leah Campbell is SRNA's Community Support Coordinator. Leah was diagnosed with neuromyelitis optica (NMO) in May 2006 after 17 years of unexplained symptoms and misdiagnosis. She was the first blind student and salutatorian of Altus High School and the first blind graduate of Rhodes College, earning a BA in mathematics. Following graduation and after a treatment for a disease she had been misdiagnosed with, she became quadriplegic and lost sensation of touch, having to relearn how to navigate life as both blind and paralyzed. She is dedicated to using her experiences to support and advocate for others.00:00 Welcome01:03 What the Rare Neuroimmune Disorders Symposium Offers02:35 Meet Sandy and Leah03:13 Origins of RNDS08:37 1999 Breakthrough Symposium12:11 Centers of Excellence Growth22:31 How RNDS Evolved31:30 Why RNDS Still Matters34:45 Leah's Journey with NMOSD35:43 Leah's RNDS Experience38:40 Advice and Closing

“Does DNA barcoding actually work?” It's the first question Kent Rapp hears from prospective customers when he pitches Biolinco's DNA barcoding platform. By his own admission, the technology can sound too good to be true.In Part 2 of this conversation, Kent rejoins the Smart Biotech Scientist Podcast to address that skepticism head-on, unpack how subclone variability and bispecific antibody purity concerns shape customer trust, and share what it actually took to move Biolinco from a Johns Hopkins postdoc project to a company with its first paying customer.In this episode:Common pushbacks and questions from industry regarding new cell line development technologies (03:18)Practical advice for resource-constrained startups developing cell lines, emphasizing efficiency and data quality over brute force automation (08:42)The role and value of DNA barcoding in screening and developing robust cell lines for therapeutics (08:56)Lessons learned from translating scientific innovation into a commercial product, including securing early support and customer trust (10:27)Insights on adapting messaging, leveraging feedback, and understanding market needs as part of the entrepreneurial process (13:52)Key differences between academic research and industry requirements for reliable, repeatable biotech tools (15:26)Kent's most important takeaway for successful cell line development: focus on collecting the right data at the right scale for informed decisions (17:14)Smart insight: Translating innovations from academia to industry brings a new wave of challenges. Kent describes the “valley of death” separating a publishable prototype from a reliable, commercial-grade product. Academic success is often tied to novelty, publications, and grants, while industry demands repeatability, robustness, and consistent performance across labs and operators. Securing early champions and funding, iterating based on tough industry feedback, and building trust with initial partners all require resilience, and a willingness to pivot as needed. Feedback, even when harsh, becomes a “gift” that helps refine the product and business model. The secret is not a single breakthrough, but adaptability and relentless customer focus.If this got you rethinking how you screen clones, you'll want these next. We've tackled cell line development, high-throughput screening, and the art of spotting manufacturable candidates early from a few different directions — here are four worth queuing up.Episodes 117 - 118 : Cell Line Development Secrets: Eliminating Critical Bottlenecks for Faster Timelines with Andrea GoughEpisodes 09 - 10: Revolutionizing Cell-Line Development: Unleashing the Power of Nanopens and Microenvironments with Tanner NevillEpisodes 123 - 124: Manufacturability: Why Most Protein Candidates Fail (And How to Pick Winners Early) with Susan SharfsteinEpisodes 115 - 116: Revolutionizing Biologics Development with Hyper Throughput Screening and AI with Jeremy AgrestiConnect with Kent Rapp:LinkedIn: www.linkedin.com/in/kent-rapp Biolinco website: www.biolinco.comFree 5-day email course, The CMC Failure Chain: the five recurring CMC mistakes that put your promising program at risk → Get it hereSupport the show

Welcome to The Education Evolution — and you're listening to Hall Pass to the Real World.What happens when you remove the grades?The University of Michigan is eliminating letter grades for first-semester freshmen beginning in fall 2027, replacing them on official transcripts with a pass/no-credit system. The goal is to reduce anxiety, support student mental health, and give freshmen room to explore without the pressure of a bad grade following them.But is removing the grade actually solving the problem—or just hiding it?In this episode, we take a closer look at what grades are really doing in education, why they create so much pressure, and whether removing that pressure helps students build resilience or simply postpones the moment when they have to learn how to handle it.Because this isn't just about grades.It's about the difference between **protection and preparation**.We look at the history of grading, Michigan's own history with pass/fail, Johns Hopkins' decision to end its grade-covering policy, and universities that have continued to use versions of pass/fail successfully.And we ask a bigger question:Are we helping students learn how to navigate discomfort, failure, feedback, and pressure—or are we simply making those things harder to see?The mental health challenges facing college students are real. But if the system itself isn't changing, does removing one of its most visible sources of pressure actually build the capacity students need to succeed?Maybe the question isn't whether pass/fail works.Maybe the real question is: **What has to be true about an educational system for it to work?**

Around this time every year, dozens of parents of high school prospects ask IL's Terry Foy some version of the question, "How does recruiting work?"In an effort to round out that answer, he's interviewing DI men's lacrosse coaches about their process, continuing the fourth year of the "How Recruiting Works" series with Johns Hopkins coach Peter Milliman.The discussion begins as Milliman's traces the evolution of his principles of play and how they intersect with the way the game is played. From there, he outlines how his staff works together to develop a recruiting board, how he relies on his relationships high school and club coaches to get feedback on prospects (sharing a favorite nugget on the topic) and ends with a discussion of how the unique elements of the Blue Jays' athletic department — chiefly being a predominantly Division III institution in the Big Ten — informs how he regards on the ongoing changes in college athletics.

Dr. Shawna Pandya is a Canadian physician, commercial astronaut, aquanaut, researcher, and international speaker working at the intersection of space medicine, human performance, technology, and extreme environments. She is the first named female Canadian commercial astronaut and is scheduled to fly aboard Virgin Galactic's Delta-class spacecraft with the International Institute for Astronautical Sciences (IIAS).Dr. Pandya serves as Director of the IIAS Space Medicine Group, Chief Instructor for Operational Space Medicine, Assistant Clinical Professor at the University of Alberta, and Chief of Space Medicine at the Advanced SpaceLife Research Institute. She is also VP of Immersive Medicine at Luxsonic Technologies and a Fellow of the Explorers' Club.Her field experience spans 12 parabolic-flight campaigns and more than 180 microgravity/reduced-gravity parabolas, two aquanaut missions totaling over 235 hours underwater, suborbital research, centrifuge training, spacecraft emergency egress, sea survival, wilderness medicine, and a command role at the Mars Desert Research Station. Her research has contributed to experiments associated with the International Space Station, Polaris Dawn, and Blue Origin.She previously trained or interned at the European Astronaut Centre and NASA Johnson Space Center and has published work covering commercial spaceflight medicine, human resilience, space technology, and long-duration space exploration.An internationally recognized speaker, Dr. Pandya has presented for organizations and institutions including the Canadian Space Agency, Oxford, Harvard, Yale, Johns Hopkins, World Extreme Medicine, and the Explorers' Club, as well as major aerospace and medical conferences worldwide.Her recognitions include being named among the Women's Executive Network Top 100 Most Powerful Women in Canada, the Explorers' Club 50 Explorers Changing the World, a Canadian Space Agency Space Ambassador, a Karman Pioneer, and a recipient of recognition from the Women's Space Awards.Dr. Pandya holds degrees in Neuroscience, Space Studies, and Medicine. Beyond medicine and spaceflight, she is an advanced and rescue diver, solo skydiver, pilot-in-training, and black belt in Taekwondo, reflecting a career built around exploration, resilience, science, and pushing the boundaries of human potential.

"If you are considering board service, I would say take the leap. Start with your local chapter. It will give you some valuable skills that will help prepare you when you are applying for your national level. And I always say, if you want to do it, just do it because what's the worst that can happen? They can say no, but that doesn't mean that you will never serve on a board. I always tell people delayed is not denied," Cassandra Green, DNP, RN, OCN®, ONS member and past president of the Oncology Nursing Certification Corporation (ONCC) Board of Directors, told Evelyn Wempe, DNP, MBA, APRN, ACNP-BC, AOCNP®, CRN, NEA-BC, chair of the ONS Leadership Succession Committee (formerly known as the Leadership Development Committee), during a conversation about service on a board of directors. Wempe spoke with Green and ONS members Kristin Ferguson, DNP, MBA, RN, OCN®, CGNC, former treasurer and director-at-large on the ONS Board of Directors, and Yanka Campbell, DNP, RN, CPHQ, AGPCNP-BC, CNE, member of the Oncology Nursing Foundation (ONF) Board of Directors, about their experiences with board service. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by August 28, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to serving on a board of directors for a professional organization. Episode Notes Complete this evaluation for free NCPD. ONS Podcast™ episodes: Meet the ONS Board of Directors series Episode 342: What It's Like to Serve on the Leadership Development Committee ONS Voice articles: Could Today Be the Start of Your ONS Leadership Journey? Nursing Leadership Unlocked Leading With Purpose Creates a Vision for the Future of Oncology Nursing ONS courses: A Guide to Chapter Leadership: Chapter President Training Board Leadership: Nurses in Governance Clinical Journal of Oncology Nursing article: Rearview Mirror Leadership: Looking Backward to Move Forward ONS Board Self-Assessment ONS Leadership ONCC Board of Directors ONF Leadership Your Roadmap to Future Service on the ONS Board of Directors ONS Leadership Learning Library To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode Campbell: "Joining a board was a natural next step for me to maintain my connection to bedside nursing that I've loved for so many years, and to find a way to give back to advanced practice nurses as well in this role. The Oncology Nursing Society and Foundation were especially meaningful for me because I knew firsthand the importance of having scholarship, research, funding, and leadership development programs that can really change the trajectory of a nurse's career. I realized I wanted to help shape the opportunities that were available to me for future nurses, and I just did not want to continue to do that through one-on-one mentorships, which I have done extensively throughout my career, but find a way to help more broadly toward guiding organizational mission and strategic objectives." TS 7:20 Green: "Everyone was so welcoming on the board. Everyone was so friendly. One of the first things I remember our executive director Tony Ellis telling me is, 'Most of our new board members are really quiet and reserved at our first meeting. They just kind of keep things to themselves. They don't ask a lot of questions.' I don't know if they were prepared for me because I came in with guns a-blazing, and I had lots of questions. I was not quiet. I was very involved and very vocal. I still am, but that was one of the best experiences ever. Before that, I had never really been in a board setting other than my local chapter, and even then, I was just starting to be in that setting because I was the president of my local chapter and on the [ONCC] Board of Directors at the same time." TS 10:29 Ferguson: "A nonclinical mentor I would absolutely identify would be Alec Stone, who used to be the ONS director of public affairs. … He helped me to learn a lot about health policy and advocacy and the impact a nurse's voice can have. Learning how to speak about my experiences in health care in public by doing programs like the Nurses in Washington Internship … or ONS's Capitol Hill Days ended up giving me a lot more confidence that I didn't know I would have in expressing my point of view and being very open and collegial and expressing my opinions. … This really lent itself well to my future board experience because, as Cassandra mentioned, board members have to speak their mind and speak up at the meetings." TS 12:11 Campbell: "One of the most unexpected benefits was when I reached out to my executive leadership team at the Kimmel Cancer Center at Johns Hopkins and said, 'I'm being considered to serve on the ONF Board. This is going to require me taking time away from work to attend meetings, to attend some in-person meetings. And then it would be really wonderful at the institution if I'm able to also financially impact the nurses who need to benefit from what I've benefited from in my career.' Usually when you have those conversations, you are expecting to present a deck of PowerPoint slides to make your case, but the answer from my leadership team in participating in ONF and supporting the Board was an immediate yes. It was 'Yes, when can you start? Yes, what can we do to support you?' And really making sure that I had dedicated time to be fully present." TS 14:15 Ferguson: "There are many skills and experiences that can lend themselves to being a strong board member. … The ability to speak your mind clearly and express your thoughts, which really boils down to strong communication skills. We are lucky in our careers. We all have worked as nurses in different settings and health care, and nurses are naturally skilled and good at communication. We learn strategies like SBAR—situation, background assessment, recommendation. Nurses every day are communicating in their places of work, oftentimes with patients who are sick and need education, or perhaps with new nurses they're teaching or mentoring. And they are communicating with non-nurses, as well, and nonpatients, so clinical roles and nonclinical roles. So nurses already have a good understanding of best practices when it comes to communication, and this can lend itself well to any board position." TS 21:04 Green: "When you [come into a] leadership role, I think that's when we learn most about ourselves and what we expect. And be the leader type of leader that you want to be and the type of leader that you would like to work with so that you can make your experience valuable and pleasurable." TS 28:57

https://eggshelltherapy.com/podcast-blog/2026/08/27/travis/Many intense people have a high level of moral sensitivity. I wrote about this elsewhere before, but basically, they see something cruel or careless and cannot just move on from it the way other people seem to. They often lie awake thinking about whether they are doing enough, whether what they are doing even counts, and whether there is any point in trying when the world does not seem to care whether they try or not. They hold themselves to standards that others think are too high, and when they fall short, they feel extremely guilty. They try to honour their values, but then they watch the news and have to hold themselves back from despair. After long enough, they start to wonder whether the whole thing is a trap they built for themselves.In this conversation, I want us to see what we can learn from a moral philosopher who has spent his career working out how ordinary humans like us can try to do good even when it seems pointless at times. Travis Rieder teaches bioethics at Johns Hopkins and wrote a book called Catastrophe Ethics.  He holds that some people are purists;  once they find out they are part of something harmful, they get themselves out of it. Others are nihilists, and they think that when the problem is this big, nothing they do counts, so there is nothing they owe anybody. Travis has watched many students come in as purists, wear themselves out, and leave as nihilists. We also talk about the role of religion in all of this.  Travis says that if God could have commanded torture and that would have made torture right, the commands are not worth much, and if God commands things because they are already right, then you can work out what is right without him. Travis's thesis is that you have no duty to cut your carbon footprint, but you have good reasons to.What he leaves us with is this: sit down every so often and work out where our time and our money and our energy should go, because that is what gives our lives meaning.Eggshell Therapy and Coaching: eggshelltherapy.com/Imi Lo:  imiloimilo.comSister Channel: https://www.youtube.com/channel/UC3Zcl8ZUsu4AePugDoWtXcgFacebook: https://www.facebook.com/eggshelltransformationsNewsletters: https://eepurl.com/bykHRzDisclaimers: https://www.eggshelltherapy.com/disclaimers  Trigger Warning: This episode may cover sensitive topics including but not limited to suicide, abuse, violence, severe mental illnesses, relationship challenges, sex, drugs, alcohol addiction, psychedelics, and the use of plant medicines. You are advised to refrain from watching or listening to the YouTube Channel or Podcast if you are likely to be offended or adversely impacted by any of these topics.Disclaimer: The content provided is for informational purposes only. Please do not consider any of the content to be clinical or professional advice. None of the content can substitute professional consultation, psychotherapy, diagnosis, or any mental health intervention.  Opinions and views expressed by the host and the guests are personal views, and they reserve the right to change their opinions. The opinions of the guest do not reflect the position of this channel or Imi. We also cannot guarantee that everything mentioned is factual and completely accurate. Any action you take based on the information in this episode is taken strictly at your own risk.  For a full disclaimer, please refer to: https://www.eggshelltherapy.c...

I'm taking you through my own origin story this episode, from getting swept into a Johns Hopkins study on intellectual talent as a sixth grader to skipping straight into college at fifteen. I share how that unusual path, being identified as gifted, accelerated through school, and landing in a college honors program that clashed with my own academic ambitions, shaped the way I think about learning today. Along the way I talk about my late AP English teacher Adrian Morris, and how I completely missed the point of literature even while being taught by the best.That early misstep, wanting to read everything in its original language rather than in translation, ended up defining my life's work. I explain why I built reader.winklers.us, my free computer assisted reading tool with over a hundred classic texts, and why I deliberately left out syntax support so readers still get the meditative wrestling that makes literature transformative. I also dig into the psychology behind why this matters: how literature builds theory of mind, how naming our emotions helps us process implicit memories, and why untranslatable words like Schadenfreude and saudade reveal blind spots in our own emotional vocabulary.In this episode you will learn:(00:00) How a Johns Hopkins study on intellectual talent led me from taking the SAT in sixth grade to skipping into college at fifteen(02:43) Why my college honors program wanted humanities depth I didn't have, and how I vastly overestimated my ability to learn languages fast enough to read literature in the original(04:42) What inspired me to build reader.winklers.us, a free tool that handles the tedious dictionary work while deliberately leaving syntax to the reader for a deeper, more meditative experience(07:09) How literature builds theory of mind and why that matters for long term relationships, a concept I explore further in my book Love Quotient: Stop Dying of Thirst in an Ocean of Love(08:00) What "name it to tame it" means, and how explicit versus implicit memory processing shapes our emotional coping(09:35) Why words like Schadenfreude, Waldeinsamkeit, and saudade reveal the blind spots baked into any single language or cultureLet's connect!linktr.ee/drprandyRead, with computer assistance, the best literature the world has ever producedandrew-winkler-reading-room.overskill.appLove Quotient: Stop Dying of Thirst in an Ocean of Love Kickstarterhttps://www.kickstarter.com/projects/amwphd/love-quotient Hosted on Acast. See acast.com/privacy for more information.

The election year emptied out Washington DC, so Meredith Goldberg ran the hotel's beagle for president. In this episode of Content Amplified, Meredith, Regional Director of Marketing for the East Coast at Lore Group, explains how guest experience became her marketing discipline and how she finds cultural moments that actually land. She walks through building guest personas out of booking data (midweek one to two night stays from out of state versus longer weekend stays with double rooms that read as family travel), and why a hotel marketer wears a different hat every day across digital, CRM, social, experiences, and PR. Then she tells the Monti story: a rescue beagle at The Jefferson in DC who got a campaign video, a platform, a poster from a local artist, business cards, a cabinet of dogs from other hotels, a convention in August that infuriated housekeeping, and a spot in People magazine. Meredith also shares how she scouts milestone anniversaries, like The West Wing turning twenty, and what she did the morning after a preview event where only two creators showed up.About MeredithMeredith Goldberg is New York born and raised and has been based in Washington DC for about twenty five years, after coming for college and staying. Her first job out of school was as a matchmaker for a dating service, where she learned she was a very bad matchmaker but a very good storyteller. A stint in clothing sales, and a shirt that appeared on an episode of The O.C. for about two seconds, pulled her into marketing, and she went on to earn a marketing master's at Johns Hopkins before landing in PR at a historic DC hotel. She has worked in small luxury properties, a convention center hotel, and a resort, and she is a dog person who now makes sure every property she works with is dog friendly.Show NotesConnect with Meredith on LinkedIn: https://www.linkedin.com/in/goldbergmeredith/Follow Meredith on Instagram: https://www.instagram.com/mjg0614/Text us what you think about this episode!

In this week's episode of Medicine: The Truth, hosts Jeremy Corr and Dr. Robert Pearl go in search of the facts beneath healthcare's biggest headlines. Today's show opens with one of the hottest and least understood medical topics: experimental peptides. Pearl explains that an FDA advisory committee narrowly recommended allowing compounding pharmacies to provide six experimental peptides to patients. This is not the same as traditional FDA approval. Rather than reviewing a drug through the usual three-phase clinical trial process, the recommendation would allow suppliers to provide peptide ingredients that compounding pharmacies could use to fill prescriptions. Pearl then explains why this distinction matters. If the FDA follows the committee's recommendation, many patients may assume the peptides have been vetted like other approved medications. He warns that this could leave the nation in a medical gray zone, with broad access but little rigorous evidence on safety, effectiveness, dosing or long-term risk. The episode then turns to several follow-up stories and new medical developments, including the cyclospora outbreak, CDC leadership, pediatric e-bike injuries, AI-designed viruses, Ebola, mRNA flu vaccines and the continuing politicization of vaccine policy: The cyclospora outbreak appears to be slowing, but the total case count remains high and the exact source has not been fully confirmed. Erica Schwartz has been confirmed as CDC director, becoming the agency's first full-time leader in a year. Pearl says Schwartz has strong credentials but will face major challenges, including depleted agency staffing, infectious disease outbreaks and political pressure around vaccines. Pediatric e-scooter and e-bike injuries surpassed 2,000 incidents from 2020 to 2024, according to data from Johns Hopkins researchers. Pearl warns that more states may need to restrict use among young children. AI can design viruses that do not currently exist in nature, a new Stanford study showed. This opens possibilities for new treatments but also raising biosecurity concerns. Pearl says the technology could one day help fight antibiotic-resistant bacterial infections, but it also raises concerns about bad actors. Ebola is spreading rapidly in the Democratic Republic of Congo, with more than 1,500 deaths and a mortality rate estimated at 40% to 50%. The FDA approved the first mRNA flu vaccine, developed by Moderna, for adults 50 and older. Pearl explains that mRNA technology could improve flu vaccination by allowing scientists to update vaccines closer to the arrival of each year's viral strain. The episode closes with Pearl's strongest warning: medical decisions made on politics rather than science lead to harm. He points to President Trump's executive order changing childhood vaccine recommendations and encouraging separation of the MMR vaccine into individual measles, mumps and rubella shots. Pearl says there is no scientific evidence supporting the president's claim that the combined MMR vaccine may be dangerous, while numerous studies show it is safe, effective and lifesaving. His conclusion: when scientific evidence is overwhelming, leaders need a compelling scientific reason to deviate from it. Whether the subject is experimental peptides, AI-designed viruses, mRNA vaccines or childhood immunization, medicine cannot protect patients if politics replaces data. Tune in to hear the full discussion and subscribe to Medicine: The Truth for more fact-based analysis of the medical, scientific and policy stories shaping American healthcare. * * * Dr. Robert Pearl is the author of “ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine” about the impact of AI on the future of medicine. Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify or wherever you find podcasts. Join the conversation or suggest a guest by following the show on X and LinkedIn. The post MTT #110: Peptides, politics & the perils of medicine without evidence appeared first on Fixing Healthcare.

We’re wrapping up the offseason, one in which we’ve now dropped 11 podcasts for you, including 24 coach and/or student athlete interviews, a commissioner and a collector of college football helmets. And we are here to get you into preseason camp, into your full pads and helmets and much more with Podcast 414. This edition of the D3football.com Podcast is sponsored by GameStrat, the most reliable & fastest in-game video replay system on the market. Find out more at GameStrat.com. Johns Hopkins is the preseason No. 4 team in our Top 25 poll, and coach Dan Wodicka was glad to talk to us during the middle of the Blue Jays’ preseason camp. Find out who the new JHU starting quarterback will be, where he came from, what else he does at Johns Hopkins, and what made his teammates vote him a captain before he has ever started a single football game for the program. Why do the Blue Jays carry just 100 players this year, and how does that compare to previous seasons? Who is wearing the honored No. 3 for Johns Hopkins this season? How well will the team reload at offensive line, where they lose four starters. And how well has JHU transitioned to new quarterbacks in the recent past? We also chat with Wes Dodson, head coach at LaGrange. The Panthers had a breakthrough season, going 10-2 and winning a first-round playoff game, and are looking to continue to push the program forward, just a few years after Dodson inherited a team which would go 0-9. The football team is a huge part of the campus culture at LaGrange, which is growing but still had under 650 full-time undergraduates last year. Secondary is the biggest spot to fill for the Panthers, while Henry Broadnax is a veteran returning at quarterback for LaGrange, coming back after playing hurt last season. Plus, how will the Top 25 poll react to the big games in the first two weeks of the season? Which Week 1 games between unranked teams do we have a particular eye on? That and more in this edition of the D3football.com Around the Nation podcast. The D3football.com Around the Nation podcast is a weekly conversation during the season, twice monthly in the offseason, about NCAA Division III football, and has been running since 2007. Hit play, or subscribe to get this podcast on your mobile device. You can subscribe to the Around the Nation Podcast in Apple Podcasts, and many other places. You can also get this and any of our future Around the Nation podcasts automatically by subscribing to this RSS feed: http://www.d3blogs.com/d3football/?feed=podcast Here’s how to find us on some of the major podcasting apps: Apple Podcasts: D3football.com Around the Nation Podcast Podcast Addict: D3football.com Around the Nation Podcast iHeart Radio: D3football.com Around the Nation Podcast Spotify: D3football.com Around the Nation Podcast Photos: David Hilbert, d3photography.com; Marty Corcoran, Johns Hopkins; Rachel Staub, Washington & Jefferson

About this episode:   At the turn of the 20th century, waterborne diseases like typhoid and dysentery posed a significant threat to public health, accounting for a large part of infant mortality and overall morbidity. Enter Abel Wolman, an early graduate of Johns Hopkins' engineering program and a professor at the university's school of public health. In this episode: the story of the Baltimore-born pioneer of water sanitization and how his work in water chlorination and infrastructure set the stage for better health across the globe.  Note: This episode was produced in collaboration with the Johns Hopkins University sesquicentennial campaign.  Guest:  Graham Mooney, PhD, is an associate professor of history of medicine and epidemiology at the Johns Hopkins School of Medicine.  Host:  Ari Goldstein, MD, is a family medicine physician and a recent alum of the Johns Hopkins Bloomberg School of Public Health General Preventive Medicine Residency program. This year, Dr. Goldstein served a one-month rotation with Public Health On Call.  Show links and related content:  Heroes of Public Health: Abel Wolman—Johns Hopkins Bloomberg School of Public Health  Friend of the Thirsty—New York Times

What if everything you believe about why you are 'you' is wrong? My guest today has spent his career studying the brain at Johns Hopkins — and a few years ago, he was told he had six to twelve months to live. Today, we're talking about what he's learned on both sides of that line. We're going to get into why 'nature versus nurture' is, in his words, scientifically lazy — and what's actually shaping your personality, your preferences, even who you're attracted to. We're going to talk about a discovery about sexual sensation in the body that's only a few years old. And we're going to talk about what facing death taught him about time, gratitude, and identity that no textbook ever could. Stick around — this one gets personal fast   Connect With David Linden: Web: https://davidlinden.org Facebook: https://www.facebook.com/davidlindenauthor   Follow Dr. JC Doornick and the Makes Sense Academy:► Makes Sense Substack - https://drjcdoornick.substack.com ► Instagram: / drjcdoornick ► Substack: / drjcdoornick ►Facebook:  / makessensepodcast ►YouTube:  / drjcdoornick     MAKES SENSE PODCAST Welcome to the Makes Sense with Dr. JC Doornick Podcast. This podcast explores topics that expand human consciousness and enhance performance. On the Makes Sense Podcast, we acknowledge that it's who you are that determines how well what you do works, and that perception is subjective and an acquired taste. When you change the way you look at things, the things you look at begin to change. Welcome to the uprising of the sleepwalking masses. Welcome to the Makes Sense with Dr. JC Doornick Podcast.   SUBSCRIBE/RATE/REVIEW & SHARE our new podcast. FOLLOW Podcast: You will find a "Follow" button in the top right. This will enable the podcast software to alert you when a new episode launches each week. Apple: https://podcasts.apple.com/ca/podcast/makes-sense-with-dr-jc-doornick/id1730954168 Spotify: https://open.spotify.com/show/1WHfKWDDReMtrGFz4kkZs9?si=003780ca147c4aec   Podcast Affiliates: Kwik Learning: Many people ask me where I get all these topics, which I've been covering for almost 15 years. I have learned to read nearly four times faster and retain information 10 times better with Kwik Learning. Learn how to learn and earn with Jim Kwik. Get his program at a special discount here: https://jimkwik.com/dragon OUR SPONSORS: Operly - Take Back Control of Your Work Day and Get Rid of All Your AI Apps - Welcome to the new world of Time Freedom and Unlimited Scaling and Success with Operly -  https://go.getoperly.ai/video?ref=jean-claude-claude-d-2a95 Blue Blinds Bakery - Handcrafted with all-natural ingredients - www.blueblindsbakery.com     DAVID LINDEN TIMESTAMP 00:00 - Cold Open and Meeting Dr. David Linden 03:08 - Facing Cancer: David's Diagnosis and JC's Own News 06:00 - Why "Unique" Needed to Be Written 09:49 - The Third Factor: Why Identical Twins Differ 13:30 - The Heritability Spectrum: Earwax to Accent 17:11 - Intelligence, Addiction and Personal Responsibility 22:32 - Why Healthy People Still Get Cancer 24:58 - When Individuality Begins: Life Before Birth 29:39 - Cilantro, Taste and the "Anti-Panda" Diet 32:54 - Diet Advice and the Truth About Supplements 36:32 - Certainty, Curiosity and the Scientist's Mindset 39:24 - Science Evolving: Being Wrong and Staying Humble 44:25 - Open Questions: Sexuality and Revising "Unique" 47:35 - Lightning Round: Myths, Memory and a Favorite Book 52:39 - ending: New Book, Where to Find David and Sign-Off  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

About this episode:   Long flights at high altitudes can expose pilots and flight attendants to dangerous levels of cosmic radiation over their careers, potentially increasing their risk for a variety of cancers and posing special dangers to pregnant crewmembers. In this episode: a new report from the National Academies of Sciences, Engineering, and Medicine urges action on in-flight radiation exposure, including mandating airline safety programs and developing new ways to measure hazards. Guest:  Tom Burke, PhD, MPH, is an emeritus professor at Johns Hopkins and a former top official with the Environmental Protection Agency in the Obama administration. Lindsay S. Fenwick is an accomplished pilot with over 21,000 flight hours spanning military, corporate, VIP, and major airline operations. He also has extensive experience in aviation safety management. Host:  Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. He served as the Baltimore City Commissioner of Health from 2005 to 2009.  Show links and related content:  Assessing Radiation Exposure, Health Outcomes, and Mitigation Strategies for Flight Crewmembers—National Academies of Sciences, Engineering, and Medicine Aircrew and Cosmic Ionizing Radiation—CDC Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌PublicHealthPod on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

GLP-1 receptor agonists have transformed weight loss and metabolic health—but what are we overlooking? In this episode of New Frontiers in Functional Medicine, Dr. Kara Fitzgerald is joined by Dr. Sanjay Bhojraj and Dr. Alexis Gonzales to explore the clinical tradeoffs of GLP-1 therapy, including lean muscle preservation, nutrient status, weight regain, and long-term metabolic health. The conversation also examines SiPore, an engineered silica-based intervention that works locally in the GI tract to slow the breakdown and absorption of carbohydrates and fats. Dr. Fitzgerald and her guests discuss findings from the randomized, double-blind, placebo-controlled SHINE trial, including outcomes related to A1c, visceral fat, waist circumference, cholesterol, and lean mass. They also explore how CGMs can reveal post-meal glucose patterns, why muscle preservation matters during weight loss, and how clinicians can support patients transitioning off GLP-1 medications—including those preparing for pregnancy, IVF, or surgery. Full show notes + references: https://www.drkarafitzgerald.com/fxmed-podcast/ GUEST DETAILS Sanjay Bhojraj, MD, FACC is an interventional cardiologist and Fellow of the American Academy of Anti-Aging Medicine specializing in cardiometabolic health, longevity medicine, and precision cardiovascular prevention. He's the founder of the Laguna Institute of Functional Medicine. His programs focus on reversing metabolic dysfunction, improving resilience, and reducing cardiovascular risk through lifestyle optimization and advanced diagnostic testing. Dr. Alexis Gonzales ("Dr. G") is OvationLab's Senior Clinical Implementation and AI Specialist, translating breakthrough research into practical clinical workflows, and holds advanced degrees in biochemistry (Saint Mary's), biotechnology (Johns Hopkins), and naturopathic medicine (Bastyr). She provides concierge functional-medicine care at her private practice in California—focusing on endometriosis, fertility, PCOS, and menopause—while distilling emerging research into practical frameworks at conferences to make integrative solutions accessible. http://sigridpro.com/DRKF THANK YOU TO OUR SPONSOR SIGRID http://sigridpro.com/DRKF *CONNECT with DrKF* Want more? Join our newsletter here: https://www.drkarafitzgerald.com/newsletter/ Or take our pop quiz and test your BioAge! https://www.drkarafitzgerald.com/bioagequiz YouTube: https://tinyurl.com/hjpc8daz Instagram: https://www.instagram.com/drkarafitzgerald/ Facebook: https://www.facebook.com/DrKaraFitzgerald/ DrKF Clinic: Patient consults with DrKF physicians including Younger You Concierge: https://tinyurl.com/yx4fjhkb Younger You Practitioner Training Program: https://www.drkarafitzgerald.com/trainingyyi/ Younger You book: https://tinyurl.com/mr4d9tym Better Broths and Healing Tonics book: https://tinyurl.com/3644mrfw Younger You book: https://tinyurl.com/mr4d9tym Better Broths and Healing Tonics book: https://tinyurl.com/3644mrfw

Our hearts are restless, says Saint Augustine, until they find their rest in God. The biological science and the spiritual metaphor are in agreement here. Over the course of billions of beats, our hearts never stop to rest.  Your magnificent heart exchanges or pumps your entire blood volume, just over a gallon, every single minute. (Athlete hearts can pump up to 10 gallons per minute!) In this episode, Mark Labberton discusses matters of the heart with his close friend Dr. David Anderson, a cardiologist of four decades who trained at Johns Hopkins and helped launch one of the first interventional cardiology programs in San Francisco. Anderson reflects on the medical science of cardiology, the profound life-saving medical advances over the past forty years, heart disease versus coronary artery disease, how the brain and the heart communicate, and what happens during a heart attack. In the second half of their conversation, they move from physiology to spirituality of the heart: Pharaoh's hardened heart, "out of the heart the mouth speaks," and the human need to find somewhere to locate the self. Anderson closes with what a cardiologist would tell anyone worried about their own heart, and with a case for medicine as a noble profession. Episode Highlights "When I first began in cardiology, if your heart was damaged, imagining that the heart could actually improve its function was like imagining someone could grow back a new arm." "One of the distinctive things about the heart is unlike other muscles, it doesn't have a time to rest. When it gets insufficient blood supply, it can't just say, 'Whoa, I'm gonna stop here.' It asks you to slow down because it starts hurting." "I think that's part of the intrigue of the heart, that it is inside us … but in some ways it's apart from us. It's responding to environmental things that we're not really even aware of. … I think it's this sense of detachment of the heart from us—but yet its centrality—that has led people to posit the soul or the will or the passions or almost anything that you would think was the real you. "Atherosclerosis … I would describe as it's like having a pimple inside your artery." "First of all, know yourself. That is, it's not a time to be fatalistic because your father had a heart attack in his fifties or your brother just had a heart attack. It's a time to be proactive." About David Anderson David Anderson is a cardiologist who practiced for more than four decades before retiring. He studied at Stanford as an undergraduate and earned his medical degree at Johns Hopkins University School of Medicine. He stayed at Hopkins for residency, then trained in San Francisco at the dawn of interventional cardiology, helping to build an angioplasty program in the early 1980s. Helpful Links and Resources Alta Bates Summit Medical Center, Sutter Health, the Oakland hospital Anderson thanks by name: https://www.sutterhealth.org/about-us/our-hospitals/alta-bates-summit-medical-center DeWood et al., "Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial Infarction," the 1980 study that identified clot as the cause of heart attack: https://www.nejm.org/doi/full/10.1056/NEJM198010163031601 Waagstein et al., "Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy," the Swedish beta-blocker work behind the recovery he describes: https://pubmed.ncbi.nlm.nih.gov/1191416/ What Is Atherosclerosis, National Heart, Lung, and Blood Institute: https://www.nhlbi.nih.gov/health/atherosclerosis Warning Signs of a Heart Attack, American Heart Association: https://www.heart.org/en/health-topics/heart-attack/warning-signs-of-a-heart-attack Angina (Chest Pain), American Heart Association, on the exertional pain he describes at the close: https://www.heart.org/en/health-topics/heart-attack/angina-chest-pain Show Notes The impact of family gene pool, lifelong heart awareness How David Anderson got into medicine, and cardiology in particular A Hopkins autopsy elective, a teenager dead in a parking lot, a mentor who followed From internists interested in the heart to interventionists inside it Catheters, pressures, and the arrival of echocardiography Seeing a beating heart inside a living body for the first time, as a senior resident A colleague's heart attack in 1979 The 1980 angiography study that identified clot as the trigger Spring 1983: an artery occludes, the cath lab opens it, pain gone in fifteen minutes Bypass surgery before that: elective, scheduled, never mid-attack Prevention running under the technology: blood pressure, smoking, the lipid theory Fixing one artery and never having to fix another Coronary artery disease versus disease of the muscle itself Plasticity, not regeneration Adrenaline as an emergency system built for days, not decades Moving from technological advances to molecular-based understanding of heart problems Understanding of the pathophysiology of atherosclerosis and its prevention Beta blockers, ejection fraction, and hearts that came back The heart as a muscle with no rest The heart's own electrical center, and the backup pacemakers below it Your heart doesn't rely on you or your consciousness to beat Why the ancients may have located the self in the heart organ Jeremiah's pounding heart, Pharaoh's hardened one Pascal, the soul, and needing somewhere to put "the real you" Maintaining an appropriate degree of separation from the patient and their family in order to care properly and effectively The difficulty of delivering bad news to patients and their familes Digging for a shared history to call on in a crisis "Medicine is a noble profession." Heart care advice from a cardiologist: First, know yourself. Heart health checklist: cholesterol, blood pressure, weight, knowing your own history The pain that warrants a phone call #Conversing #MarkLabberton #Cardiology #Heart #MedicalScience #HeartHealth #Biology #ChristianHumanism Production Credits Conversing is produced and distributed in partnership with Comment magazine and Fuller Seminary.

He moved to Hollywood with $43 and a dream. Watched his dad pour brilliant ideas into businesses that made other people rich. Decided the only thing scarier than risking everything was never finding out what he was capable of. Twenty-five years and 51 countries later, Caleb Gilbert protects the world's most elite. And everything he's learned doing it maps directly into how you're building your business right now. Caleb Gilbert is the founder of White Glove Protection Group and a global expert in executive protection. In this conversation, he and George translate the frameworks used to protect A-list celebrities and Fortune 200 companies into a masterclass on entrepreneurship, covering risk, trust, vision, proactive vs. reactive posture, and what it really means to be all in. What You'll Learn In This Episode: How executive protection frameworks apply directly to building a business Why your relevance is entirely based on the perceived value of your consumer The difference between being energetically all in vs. financially all in Why Caleb turned down $1.5M in business to protect his vision and how it led to 4,000% growth How to build a proactive business posture instead of a reactive one The one question that revealed imposter syndrome was costing him clients Why grit, not tactics, is the most transferable skill from protection to entrepreneurship Key Takeaways: ✔️Your relevance is based on the perceived value of your consumer, not what you think they need. Flip the script. ✔️Being energetically all in and being financially all in are not the same thing. The people around you will tell you when you're truly all in, they'll tell you you're overdoing it. ✔️Zero revenue for two years. Turned down $1.5M. Then 4,000% growth. Knowing your vision and protecting it is a competitive strategy. ✔️Proactive posture beats reactive posture every time, in protection and in business. Stop waiting for the threat. Get ahead of it. ✔️The biggest threat your business faces is distraction. Not competition. Not market conditions. Distraction. ✔️Nobody else has your brain, your context, your background. The moment Caleb stopped trying to be a Navy SEAL and started leading with his actual edge, everything changed. ✔️Don't let money be your north star. If vision, strategy, and execution align with what the market needs, the money follows. ✔️Reinvest like you're still building. A $1.50 lawn mower became a business, because every dollar went back in. Timestamps & Highlights: [00:00] — $43, a dream, and the mindset that made it work [01:26] — Welcome: 25 years, 51 countries, and the White Glove difference [03:16] — Montana grit: why hard things inspire instead of dissuade [06:28] — Environment that demands vs. inspires and what that means for your team [07:33] — Starting at age 11: Nike socks, lawn mowers, and learning risk vs. reward early [11:03] — How to mitigate risk without impeding what makes your business great [13:07] — "Your relevance is based on the perceived value of your consumer" [18:00] — The onboarding parallel: walking clients through what they've never experienced [21:00] — Client number one, staying in vision, and zero revenue for two years [24:17] — Energetically all in vs. financially all in, how to tell the difference [28:34] — The 2020 gut check: when a CEO told Caleb not to chase money [35:00] — Ego in the protection industry and how Caleb navigated it [43:00] — Imposter syndrome, 86% prior military, and the moment he found his edge [50:00] — Proactive vs. reactive posture in business and protection [55:00] — Reinvesting like you're still building: the $1.50 lawn mower origin story [59:43] — Caleb's closing wisdom: be proactive, know your strengths, hit refresh Connect with Caleb Gilbert:  Founder and President of White Glove Protection Group, with 25 years of executive protection experience across 51 countries. He holds a Master's in Global Security Studies from Johns Hopkins and has trained at Stanford and ESI. He currently serves as Vice Chair of the ASIS Executive Protection Community and Treasurer of the IPSB Board. LinkedIn: linkedin.com/in/epcaleb Instagram: instagram.com/w.g.p.group.inc YouTube: youtube.com/channel/UCepN8VJqAXFahvbtfHxdcoQ Website: whitegloveprotection.com Your Challenge This Week: What's the one thing from this episode you can apply tomorrow: grit, proactive posture, protecting your vision, or leaning into your actual edge? Let George know. And if you have a security question for Caleb, he genuinely welcomes the conversation. Follow George: @itsgeorgebryant Work with George: The Alliance — Community for entrepreneurs building with vision, grit, and integrity. 1:1 Coaching — Limited spots. Apply at mindofgeorge.com/coaching-consulting/ Live Retreats — In-person experiences for entrepreneurs ready to stop reacting and start leading.